| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF823 ZNF717 ZNF487 ZNF567 ZNF132 ZNF135 ZNF536 ZFP90 ZNF143 ZNF613 ZNF555 ZBTB17 ZSCAN31 ZNF391 ZNF460 ZNF366 ZNF268 ZSCAN5A ZNF175 ZNF549 ZNF423 ZNF180 ZNF329 PEG3 TRPS1 ZNF300 OSR2 ZNF322 ZKSCAN7 CHD7 REST ZNF236 ZFP69 ZIM3 ZNF891 ZNF835 ZNF710 ZNF77 THAP11 ZNF7 ZNF12 ZFHX4 ZNF334 ZNF544 GLI4 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 ZNF614 GLIS1 ZNF554 ZNF124 ZNF646 | 1.05e-25 | 1459 | 178 | 61 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF823 ZNF717 ZNF487 ZNF132 ZNF135 ZNF536 ZFP90 ZNF143 ZNF555 ZBTB17 ZSCAN31 ZNF391 ZNF460 ZNF268 ZSCAN5A ZNF175 ZNF549 ZNF423 ZNF180 ZNF329 PEG3 TRPS1 ZNF300 OSR2 ZNF322 ZKSCAN7 REST ZNF236 ZFP69 ZIM3 ZNF891 ZNF77 THAP11 ZNF7 ZNF12 ZFHX4 ZNF334 ZNF544 GLI4 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 ZNF614 GLIS1 NOTCH1 NOTCH2 ZNF554 ZNF124 ZNF646 | 3.93e-23 | 1412 | 178 | 57 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF717 ZNF567 ZNF132 ZNF135 ZNF536 ZNF143 ZNF613 ZBTB17 ZSCAN31 ZNF460 ZNF366 ZNF268 ZSCAN5A ZNF175 ZNF549 ZNF423 ZNF300 ZNF322 ZKSCAN7 CHD7 REST ZNF236 ZIM3 ZNF835 ZNF710 THAP11 ZNF7 ZNF12 ZFHX4 ZNF334 ZNF544 GLI4 ZNF197 ZNF75D ZNF616 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 GLIS1 NOTCH1 NOTCH2 ZNF646 | 1.21e-16 | 1271 | 178 | 46 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF717 ZNF567 ZNF132 ZNF135 ZNF536 ZNF143 ZNF613 ZBTB17 ZSCAN31 ZNF460 ZNF366 ZNF268 ZSCAN5A ZNF175 ZNF549 ZNF423 ZNF300 ZNF322 ZKSCAN7 CHD7 REST ZNF236 ZIM3 ZNF835 ZNF710 THAP11 ZNF7 ZNF12 ZFHX4 ZNF334 ZNF544 GLI4 ZNF197 ZNF75D ZNF616 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 GLIS1 ZNF646 | 1.51e-15 | 1244 | 178 | 44 | GO:0000978 |
| GeneOntologyMolecularFunction | calcium ion binding | DLL4 SPOCK1 MATN1 MATN2 DNER NBPF26 SMOC2 LRP1B CRB1 ITPR1 ITPR2 ITPR3 EYS HMCN2 SCUBE2 EGF JAG1 SLIT1 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 6.25e-10 | 749 | 178 | 27 | GO:0005509 |
| GeneOntologyMolecularFunction | type I interferon receptor binding | 5.26e-09 | 17 | 178 | 6 | GO:0005132 | |
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 6.97e-07 | 3 | 178 | 3 | GO:0005220 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 7.19e-07 | 36 | 178 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 7.40e-07 | 20 | 178 | 5 | GO:0061665 | |
| GeneOntologyMolecularFunction | Notch binding | 3.66e-06 | 27 | 178 | 5 | GO:0005112 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 8.15e-05 | 50 | 178 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | molecular function activator activity | RGPD4 RGPD2 RANBP2 RGPD8 DLL4 INHA LRCOL1 ARHGAP35 IFNA4 IFNA7 TNFRSF11B IFNA10 IFNA16 IFNA17 IFNA21 NANOS2 EGF JAG1 RGPD3 CCN2 SIPA1L2 MAP2K7 NANOS1 NOTCH1 RGPD5 | 1.01e-04 | 1233 | 178 | 25 | GO:0140677 |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.08e-04 | 53 | 178 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.13e-04 | 85 | 178 | 6 | GO:0038024 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 2.36e-04 | 14 | 178 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.58e-04 | 16 | 178 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF717 ZNF143 ZBTB17 ZNF268 ZNF175 ZNF300 OSR2 THAP11 ZNF544 ZNF197 ZNF615 GLIS1 NOTCH1 NOTCH2 | 5.13e-04 | 560 | 178 | 14 | GO:0001228 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 5.15e-04 | 18 | 178 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF717 ZNF143 ZBTB17 ZNF268 ZNF175 ZNF300 OSR2 THAP11 ZNF544 ZNF197 ZNF615 GLIS1 NOTCH1 NOTCH2 | 5.69e-04 | 566 | 178 | 14 | GO:0001216 |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 6.08e-04 | 19 | 178 | 3 | GO:0005520 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 8.23e-04 | 21 | 178 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.51e-03 | 188 | 178 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | cytokine activity | 1.85e-03 | 250 | 178 | 8 | GO:0005125 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.61e-03 | 31 | 178 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.71e-03 | 65 | 178 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | peptide transmembrane transporter activity | 2.73e-03 | 9 | 178 | 2 | GO:1904680 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 3.12e-03 | 33 | 178 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 3.39e-03 | 10 | 178 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | DLL4 INHA IFNA4 IFNA7 TNFRSF11B IFNA10 IFNA16 IFNA17 IFNA21 EGF JAG1 CCN2 DKK2 | 3.60e-03 | 616 | 178 | 13 | GO:0030545 |
| GeneOntologyMolecularFunction | GTPase activator activity | 3.64e-03 | 279 | 178 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | receptor ligand activity | DLL4 INHA IFNA4 IFNA7 TNFRSF11B IFNA10 IFNA16 IFNA17 IFNA21 EGF JAG1 CCN2 | 3.76e-03 | 547 | 178 | 12 | GO:0048018 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 5.24e-09 | 9 | 176 | 5 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.04e-08 | 10 | 176 | 5 | GO:1903301 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.24e-08 | 20 | 176 | 6 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation of STAT protein | 1.73e-08 | 21 | 176 | 6 | GO:0033141 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation of STAT protein | 4.20e-08 | 24 | 176 | 6 | GO:0033139 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 5.20e-08 | 13 | 176 | 5 | GO:0033131 | |
| GeneOntologyBiologicalProcess | natural killer cell activation involved in immune response | 6.13e-08 | 42 | 176 | 7 | GO:0002323 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 8.04e-08 | 14 | 176 | 5 | GO:1903299 | |
| GeneOntologyBiologicalProcess | serine phosphorylation of STAT protein | 1.14e-07 | 28 | 176 | 6 | GO:0042501 | |
| GeneOntologyBiologicalProcess | response to exogenous dsRNA | 7.26e-06 | 55 | 176 | 6 | GO:0043330 | |
| GeneOntologyBiologicalProcess | natural killer cell activation | 1.14e-05 | 124 | 176 | 8 | GO:0030101 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via JAK-STAT | 1.21e-05 | 125 | 176 | 8 | GO:0046425 | |
| GeneOntologyBiologicalProcess | response to dsRNA | 1.61e-05 | 63 | 176 | 6 | GO:0043331 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus by host | 1.61e-05 | 63 | 176 | 6 | GO:0050691 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.71e-05 | 38 | 176 | 5 | GO:0000413 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 2.50e-05 | 41 | 176 | 5 | GO:0035909 | |
| GeneOntologyBiologicalProcess | regulation of receptor signaling pathway via STAT | 3.20e-05 | 143 | 176 | 8 | GO:1904892 | |
| GeneOntologyBiologicalProcess | axon guidance | MATN2 ARHGAP35 PTK7 HMCN2 MEGF9 CNTN5 SLIT1 LRP1 LRP2 NOTCH1 NOTCH2 | 3.53e-05 | 285 | 176 | 11 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | MATN2 ARHGAP35 PTK7 HMCN2 MEGF9 CNTN5 SLIT1 LRP1 LRP2 NOTCH1 NOTCH2 | 3.64e-05 | 286 | 176 | 11 | GO:0097485 |
| GeneOntologyBiologicalProcess | B cell differentiation | 5.92e-05 | 201 | 176 | 9 | GO:0030183 | |
| GeneOntologyBiologicalProcess | aorta development | 6.31e-05 | 80 | 176 | 6 | GO:0035904 | |
| GeneOntologyBiologicalProcess | type I interferon-mediated signaling pathway | 8.87e-05 | 85 | 176 | 6 | GO:0060337 | |
| GeneOntologyBiologicalProcess | cellular response to type I interferon | 9.47e-05 | 86 | 176 | 6 | GO:0071357 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 9.51e-05 | 124 | 176 | 7 | GO:0042100 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 9.63e-05 | 54 | 176 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | cellular response to virus | 1.22e-04 | 90 | 176 | 6 | GO:0098586 | |
| GeneOntologyBiologicalProcess | regulation of defense response to virus | 1.22e-04 | 90 | 176 | 6 | GO:0050688 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 1.38e-04 | 92 | 176 | 6 | GO:0048844 | |
| GeneOntologyBiologicalProcess | response to type I interferon | 1.38e-04 | 92 | 176 | 6 | GO:0034340 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 1.41e-04 | 132 | 176 | 7 | GO:0043255 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.54e-04 | 134 | 176 | 7 | GO:0003279 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 1.54e-04 | 134 | 176 | 7 | GO:0010906 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 2.16e-04 | 3 | 176 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-serine phosphorylation | 2.30e-04 | 101 | 176 | 6 | GO:0033138 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | RGPD4 RGPD2 RANBP2 RGPD8 INSR ITGB2 IFNA4 IFNA7 SMYD2 IFNA10 IFNA16 IFNA17 IFNA21 KAT7 EGF TTLL6 RGPD3 PRKCH ROS1 UHRF2 | 2.60e-04 | 976 | 176 | 20 | GO:0018193 |
| GeneOntologyBiologicalProcess | T cell activation involved in immune response | 2.85e-04 | 148 | 176 | 7 | GO:0002286 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via JAK-STAT | 3.08e-04 | 198 | 176 | 8 | GO:0007259 | |
| GeneOntologyBiologicalProcess | cell activation involved in immune response | MUC19 ITGB2 IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 LRP1 RAB27A NOTCH2 | 3.12e-04 | 365 | 176 | 11 | GO:0002263 |
| GeneOntologyBiologicalProcess | lymphocyte activation involved in immune response | 3.16e-04 | 251 | 176 | 9 | GO:0002285 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 3.53e-04 | 71 | 176 | 5 | GO:0006111 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 3.68e-04 | 40 | 176 | 4 | GO:0097242 | |
| GeneOntologyBiologicalProcess | axonogenesis | USP9X MATN2 ARHGAP35 PTK7 PRDM8 HMCN2 MEGF9 CNTN5 SLIT1 CNTNAP2 LRP1 LRP2 NOTCH1 NOTCH2 | 3.70e-04 | 566 | 176 | 14 | GO:0007409 |
| GeneOntologyBiologicalProcess | ventricular trabecula myocardium morphogenesis | 3.80e-04 | 17 | 176 | 3 | GO:0003222 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | RGPD4 RGPD2 RANBP2 RGPD8 INSR IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 EGF RGPD3 ROS1 CCN2 MAP2K7 NOTCH2 | 3.83e-04 | 780 | 176 | 17 | GO:0042327 |
| GeneOntologyBiologicalProcess | interferon-mediated signaling pathway | 4.02e-04 | 112 | 176 | 6 | GO:0140888 | |
| GeneOntologyBiologicalProcess | axon development | USP9X MATN2 ARHGAP35 PTK7 PRDM8 HMCN2 MEGF9 CNTN5 SLIT1 CNTNAP2 LRP1 LRP2 CTNNA1 NOTCH1 NOTCH2 | 4.16e-04 | 642 | 176 | 15 | GO:0061564 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 4.28e-04 | 74 | 176 | 5 | GO:0002011 | |
| GeneOntologyBiologicalProcess | positive regulation of BMP signaling pathway | 4.45e-04 | 42 | 176 | 4 | GO:0030513 | |
| GeneOntologyBiologicalProcess | humoral immune response | CFI IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 C1R NOTCH1 NOTCH2 | 4.51e-04 | 321 | 176 | 10 | GO:0006959 |
| GeneOntologyBiologicalProcess | cardiac chamber development | 4.85e-04 | 212 | 176 | 8 | GO:0003205 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway via STAT | 5.49e-04 | 216 | 176 | 8 | GO:0097696 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 6.13e-04 | 80 | 176 | 5 | GO:2000179 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | TNFRSF11B TFF3 CRB1 CCN2 LTBP3 MUC2 USH2A MUC5AC NANOS1 NOTCH1 | 6.14e-04 | 334 | 176 | 10 | GO:0060249 |
| GeneOntologyBiologicalProcess | tissue homeostasis | TNFRSF11B TFF3 CRB1 CCN2 LTBP3 MUC2 USH2A MUC5AC NANOS1 NOTCH1 | 6.14e-04 | 334 | 176 | 10 | GO:0001894 |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 6.26e-04 | 20 | 176 | 3 | GO:0003184 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 7.12e-04 | 5 | 176 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 7.12e-04 | 5 | 176 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | cardiac right ventricle morphogenesis | 7.25e-04 | 21 | 176 | 3 | GO:0003215 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 8.51e-04 | 231 | 176 | 8 | GO:0006109 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 8.69e-04 | 50 | 176 | 4 | GO:1905314 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 8.98e-04 | 87 | 176 | 5 | GO:0001974 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 9.00e-04 | 233 | 176 | 8 | GO:0061351 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 9.19e-04 | 131 | 176 | 6 | GO:0030510 | |
| GeneOntologyBiologicalProcess | cardiac ventricle morphogenesis | 9.45e-04 | 88 | 176 | 5 | GO:0003208 | |
| GeneOntologyBiologicalProcess | chondrocyte differentiation | 9.94e-04 | 133 | 176 | 6 | GO:0002062 | |
| GeneOntologyBiologicalProcess | artery development | 9.94e-04 | 133 | 176 | 6 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 9.95e-04 | 89 | 176 | 5 | GO:0060411 | |
| GeneOntologyBiologicalProcess | ciliary body morphogenesis | 1.06e-03 | 6 | 176 | 2 | GO:0061073 | |
| GeneOntologyBiologicalProcess | pulmonary artery morphogenesis | 1.06e-03 | 6 | 176 | 2 | GO:0061156 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 1.06e-03 | 6 | 176 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 1.07e-03 | 135 | 176 | 6 | GO:2000177 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 1.08e-03 | 24 | 176 | 3 | GO:0003177 | |
| GeneOntologyBiologicalProcess | leukocyte activation involved in immune response | MUC19 ITGB2 IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 RAB27A NOTCH2 | 1.11e-03 | 361 | 176 | 10 | GO:0002366 |
| GeneOntologyBiologicalProcess | regulation of peptidyl-serine phosphorylation | 1.16e-03 | 137 | 176 | 6 | GO:0033135 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | DLL4 MATN1 INSR MUC19 OSR2 CHD7 REST TNFRSF11B CRB1 PTK7 ITPR1 SCUBE2 MEGF9 JAG1 SLIT1 LRP2 CCN2 LTBP3 CTNNA1 USH2A NOTCH1 NOTCH2 | 1.22e-03 | 1269 | 176 | 22 | GO:0009887 |
| GeneOntologyBiologicalProcess | gliogenesis | MATN2 DNER ADAM22 CRB1 PRDM8 CNTNAP2 LRP1 LRP2 PRKCH NOTCH1 NOTCH2 | 1.32e-03 | 435 | 176 | 11 | GO:0042063 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ZNF135 USP9X MATN1 MATN2 REST ARHGAP35 ITGB2 CRB1 PTK7 ITPR1 PRDM8 HMCN2 MEGF9 CNTN5 SLIT1 CNTNAP2 LRP1 LRP2 NOTCH1 ZMYM3 NOTCH2 | 1.32e-03 | 1194 | 176 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of osteoblast differentiation | 1.33e-03 | 192 | 176 | 7 | GO:0045667 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.82e-09 | 8 | 185 | 5 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.25e-08 | 10 | 185 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 9.65e-08 | 14 | 185 | 5 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 4.01e-07 | 18 | 185 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 7.16e-07 | 20 | 185 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 9.33e-07 | 21 | 185 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 5.51e-05 | 9 | 185 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.07e-04 | 11 | 185 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | basement membrane | 1.08e-04 | 122 | 185 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | mucus layer | 2.32e-04 | 3 | 185 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | nuclear pore | 2.80e-04 | 101 | 185 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | matrilin complex | 4.62e-04 | 4 | 185 | 2 | GO:0120216 | |
| GeneOntologyCellularComponent | inclusion body | 1.23e-03 | 90 | 185 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | extracellular matrix | LAMB4 MATN1 MATN2 SMOC2 TNFRSF11B EYS HMCN2 MEGF9 NID1 CCN2 LTBP3 MUC2 USH2A MUC5AC | 2.17e-03 | 656 | 185 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMB4 MATN1 MATN2 SMOC2 TNFRSF11B EYS HMCN2 MEGF9 NID1 CCN2 LTBP3 MUC2 USH2A MUC5AC | 2.23e-03 | 658 | 185 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 2.44e-03 | 153 | 185 | 6 | GO:0097731 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 1.89e-07 | 16 | 122 | 5 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 2.65e-06 | 26 | 122 | 5 | MP:0012058 | |
| MousePheno | decreased tumor latency | 5.58e-06 | 30 | 122 | 5 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 6.61e-06 | 31 | 122 | 5 | MP:0012129 | |
| MousePheno | absent corpus callosum | 9.10e-06 | 33 | 122 | 5 | MP:0002196 | |
| MousePheno | abnormal tumor latency | 1.06e-05 | 34 | 122 | 5 | MP:0010307 | |
| MousePheno | abnormal epididymis size | 1.46e-05 | 166 | 122 | 9 | MP:0004926 | |
| MousePheno | abnormal blastocyst formation | 2.12e-05 | 39 | 122 | 5 | MP:0012128 | |
| MousePheno | abnormal epididymis morphology | RGPD4 RGPD2 RANBP2 RGPD8 ZNF236 C3orf20 ITPR1 ZC3H4 RGPD3 ROS1 ZMYM3 | 2.32e-05 | 269 | 122 | 11 | MP:0002631 |
| MousePheno | increased cochlear hair cell number | 2.40e-05 | 20 | 122 | 4 | MP:0004407 | |
| MousePheno | enlarged epididymis | 2.49e-05 | 99 | 122 | 7 | MP:0004931 | |
| MousePheno | abnormal cochlear outer hair cell number | 7.22e-05 | 50 | 122 | 5 | MP:0004400 | |
| MousePheno | abnormal hippocampal commissure morphology | 9.61e-05 | 28 | 122 | 4 | MP:0008221 | |
| MousePheno | abnormal corpus callosum morphology | 1.35e-04 | 129 | 122 | 7 | MP:0000780 | |
| MousePheno | abnormal dorsal telencephalic commissure morphology | 1.55e-04 | 132 | 122 | 7 | MP:0008219 | |
| MousePheno | aneuploidy | 1.88e-04 | 61 | 122 | 5 | MP:0004024 | |
| MousePheno | increased cochlear inner hair cell number | 2.20e-04 | 14 | 122 | 3 | MP:0004395 | |
| MousePheno | abnormal stapes footplate morphology | 2.25e-04 | 3 | 122 | 2 | MP:0004290 | |
| MousePheno | otosclerosis | 2.25e-04 | 3 | 122 | 2 | MP:0004897 | |
| MousePheno | increased incidence of tumors by chemical induction | 2.33e-04 | 141 | 122 | 7 | MP:0004499 | |
| MousePheno | incomplete embryo turning | 2.54e-04 | 65 | 122 | 5 | MP:0001701 | |
| MousePheno | decreased bone mineral density | USP53 TRPS1 SMOC2 ITGB2 TNFRSF11B SCUBE2 SCUBE3 ZNF616 CCN2 ARHGEF4 UHRF2 DKK2 NOTCH2 | 2.62e-04 | 476 | 122 | 13 | MP:0000063 |
| MousePheno | abnormal cochlear hair cell number | 3.13e-04 | 68 | 122 | 5 | MP:0004406 | |
| MousePheno | abnormal inner ear morphology | USP53 CHD7 REST TNFRSF11B PTK7 JAG1 SCUBE3 LRP2 USH2A NOTCH1 | 3.20e-04 | 303 | 122 | 10 | MP:0000026 |
| MousePheno | abnormal susceptibility to hearing loss | 3.24e-04 | 38 | 122 | 4 | MP:0006334 | |
| MousePheno | increased cochlear outer hair cell number | 3.34e-04 | 16 | 122 | 3 | MP:0004401 | |
| MousePheno | abnormal craniofacial development | CRIM1 TRPS1 OSR2 ELP1 CHD7 THAP11 KAT7 ZFHX4 CCN2 LTBP3 DISP1 NOTCH1 | 3.38e-04 | 425 | 122 | 12 | MP:0003935 |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 3.44e-04 | 107 | 122 | 6 | MP:0003694 | |
| MousePheno | increased hepatocellular carcinoma incidence | 3.59e-04 | 70 | 122 | 5 | MP:0003331 | |
| MousePheno | increased sensory neuron number | 4.36e-04 | 41 | 122 | 4 | MP:0006006 | |
| MousePheno | coloboma | 4.36e-04 | 41 | 122 | 4 | MP:0005262 | |
| MousePheno | abnormal blastocyst hatching | 4.61e-04 | 113 | 122 | 6 | MP:0003693 | |
| MousePheno | abnormal cochlear outer hair cell morphology | 4.84e-04 | 159 | 122 | 7 | MP:0004399 | |
| MousePheno | abnormal brain commissure morphology | 5.22e-04 | 161 | 122 | 7 | MP:0002199 | |
| MousePheno | increased lung carcinoma incidence | 5.92e-04 | 78 | 122 | 5 | MP:0008714 | |
| MousePheno | abnormal rod electrophysiology | 6.07e-04 | 119 | 122 | 6 | MP:0004021 | |
| Domain | zf-C2H2 | ZNF823 ZNF567 ZNF132 ZNF135 ZNF536 ZFP90 ZNF143 ZNF613 ZNF555 ZBTB17 ZSCAN31 ZNF391 ZNF460 ZNF366 ZNF268 ZSCAN5A ZNF175 ZNF549 ZNF423 ZNF180 ZNF329 PEG3 TRPS1 ZNF300 OSR2 ZNF200 ZNF322 ZKSCAN7 REST ZNF235 ZNF236 ZFP69 ZIM3 ZNF891 ZNF835 ZNF710 ZNF77 ZNF7 ZNF12 PRDM8 ZFHX4 ZNF334 ZNF544 GLI4 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 ZNF614 GLIS1 ZNF222 ZNF554 ZNF124 ZNF646 | 1.54e-42 | 693 | 177 | 61 | PF00096 |
| Domain | - | ZNF823 ZNF567 ZNF132 ZNF135 ZNF536 ZFP90 ZNF143 ZNF613 ZNF555 ZBTB17 ZSCAN31 ZNF391 ZNF460 ZNF366 ZNF268 ZSCAN5A ZNF175 ZNF549 ZNF423 ZNF180 ZNF329 PEG3 ZNF300 OSR2 ZNF200 ZNF322 ZKSCAN7 REST ZNF235 ZNF236 ZFP69 ZIM3 ZNF891 ZNF835 ZNF710 ZNF77 ZNF7 ZNF12 PRDM8 ZFHX4 ZNF334 ZNF544 GLI4 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 ZNF614 GLIS1 ZNF222 ZNF554 ZNF124 ZNF646 | 6.92e-42 | 679 | 177 | 60 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF823 ZNF567 ZNF132 ZNF135 ZNF536 ZFP90 ZNF143 ZNF613 ZNF555 ZBTB17 ZSCAN31 ZNF391 ZNF460 ZNF366 ZNF268 ZSCAN5A ZNF175 ZNF549 ZNF423 ZNF180 ZNF329 PEG3 ZNF300 OSR2 ZNF200 ZNF322 ZKSCAN7 REST ZNF235 ZNF236 ZFP69 ZIM3 ZNF891 ZNF835 ZNF710 ZNF77 ZNF7 ZNF12 PRDM8 ZFHX4 ZNF334 ZNF544 GLI4 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 ZNF614 GLIS1 ZNF222 ZNF554 ZNF124 ZNF646 | 2.47e-41 | 694 | 177 | 60 | IPR013087 |
| Domain | Znf_C2H2-like | ZNF823 ZNF567 ZNF132 ZNF135 ZNF536 ZFP90 ZNF143 ZNF613 ZNF555 ZBTB17 ZSCAN31 ZNF391 ZNF460 ZNF366 ZNF268 ZSCAN5A ZNF175 ZNF549 ZNF423 ZNF180 ZNF329 PEG3 TRPS1 ZNF300 OSR2 ZNF200 ZNF322 ZKSCAN7 REST ZNF235 ZNF236 ZFP69 ZIM3 ZNF891 ZNF835 ZNF710 ZNF77 ZNF7 ZNF12 KAT7 PRDM8 ZFHX4 ZNF334 ZNF544 GLI4 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 ZNF614 GLIS1 ZNF222 ZNF554 ZNF124 ZNF646 | 4.16e-40 | 796 | 177 | 62 | IPR015880 |
| Domain | Znf_C2H2 | ZNF823 ZNF567 ZNF132 ZNF135 ZNF536 ZFP90 ZNF143 ZNF613 ZNF555 ZBTB17 ZSCAN31 ZNF391 ZNF460 ZNF366 ZNF268 ZSCAN5A ZNF175 ZNF549 ZNF423 ZNF180 ZNF329 PEG3 TRPS1 ZNF300 OSR2 ZNF200 ZNF322 ZKSCAN7 REST ZNF235 ZNF236 ZFP69 ZIM3 ZNF891 ZNF835 ZNF710 ZNF77 ZNF7 ZNF12 KAT7 PRDM8 ZFHX4 ZNF334 ZNF544 GLI4 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 ZNF614 GLIS1 ZNF222 ZNF554 ZNF124 ZNF646 | 8.11e-40 | 805 | 177 | 62 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF823 ZNF567 ZNF132 ZNF135 ZNF536 ZFP90 ZNF143 ZNF613 ZNF555 ZBTB17 ZSCAN31 ZNF391 ZNF460 ZNF366 ZNF268 ZSCAN5A ZNF175 ZNF549 ZNF423 ZNF180 ZNF329 PEG3 TRPS1 ZNF300 OSR2 ZNF200 ZNF322 ZKSCAN7 REST ZNF235 ZNF236 ZFP69 ZIM3 ZNF891 ZNF835 ZNF710 ZNF77 ZNF7 ZNF12 KAT7 PRDM8 ZFHX4 ZNF334 ZNF544 GLI4 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 ZNF614 GLIS1 ZNF222 ZNF554 ZNF124 ZNF646 | 1.01e-39 | 808 | 177 | 62 | SM00355 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF823 ZNF567 ZNF132 ZNF135 ZNF536 ZFP90 ZNF143 ZNF613 ZNF555 ZBTB17 ZSCAN31 ZNF391 ZNF460 ZNF366 ZNF268 ZSCAN5A ZNF175 ZNF549 ZNF423 ZNF180 ZNF329 PEG3 TRPS1 ZNF300 OSR2 ZNF200 ZNF322 ZKSCAN7 REST ZNF235 ZNF236 ZFP69 ZIM3 ZNF891 ZNF835 ZNF710 ZNF77 ZNF7 ZNF12 PRDM8 ZFHX4 ZNF334 ZNF544 GLI4 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 ZNF614 GLIS1 ZNF222 ZNF554 ZNF124 ZNF646 | 1.13e-39 | 775 | 177 | 61 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF823 ZNF567 ZNF132 ZNF135 ZNF536 ZFP90 ZNF143 ZNF613 ZNF555 ZBTB17 ZSCAN31 ZNF391 ZNF460 ZNF366 ZNF268 ZSCAN5A ZNF175 ZNF549 ZNF423 ZNF180 ZNF329 PEG3 TRPS1 ZNF300 OSR2 ZNF200 ZNF322 ZKSCAN7 REST ZNF235 ZNF236 ZFP69 ZIM3 ZNF891 ZNF835 ZNF710 ZNF77 ZNF7 ZNF12 PRDM8 ZFHX4 ZNF334 ZNF544 GLI4 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 ZNF614 GLIS1 ZNF222 ZNF554 ZNF124 ZNF646 | 1.31e-39 | 777 | 177 | 61 | PS00028 |
| Domain | KRAB | ZNF823 ZNF567 ZNF132 ZNF135 ZFP90 ZNF613 ZNF555 ZNF460 ZNF268 ZNF175 ZNF549 ZNF180 ZNF300 ZKSCAN7 ZNF235 ZFP69 ZIM3 ZNF891 ZNF77 ZNF7 ZNF12 ZNF334 ZNF544 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZNF614 ZNF222 ZNF554 ZNF124 | 7.58e-28 | 358 | 177 | 37 | PS50805 |
| Domain | KRAB | ZNF823 ZNF567 ZNF132 ZNF135 ZFP90 ZNF613 ZNF555 ZNF460 ZNF268 ZNF175 ZNF549 ZNF180 ZNF300 ZKSCAN7 ZNF235 ZFP69 ZIM3 ZNF891 ZNF77 ZNF7 ZNF12 ZNF334 ZNF544 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZNF614 ZNF222 ZNF554 ZNF124 | 7.58e-28 | 358 | 177 | 37 | PF01352 |
| Domain | KRAB | ZNF823 ZNF567 ZNF132 ZNF135 ZFP90 ZNF613 ZNF555 ZNF460 ZNF268 ZNF175 ZNF549 ZNF180 ZNF300 ZKSCAN7 ZNF235 ZFP69 ZIM3 ZNF891 ZNF77 ZNF7 ZNF12 ZNF334 ZNF544 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZNF614 ZNF222 ZNF554 ZNF124 | 2.27e-27 | 369 | 177 | 37 | SM00349 |
| Domain | KRAB | ZNF823 ZNF567 ZNF132 ZNF135 ZFP90 ZNF613 ZNF555 ZNF460 ZNF268 ZNF175 ZNF549 ZNF180 ZNF300 ZKSCAN7 ZNF235 ZFP69 ZIM3 ZNF891 ZNF77 ZNF7 ZNF12 ZNF334 ZNF544 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZNF614 ZNF222 ZNF554 ZNF124 | 2.50e-27 | 370 | 177 | 37 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF823 ZNF567 ZNF135 ZFP90 ZNF613 ZNF555 ZSCAN31 ZNF391 ZNF366 ZNF549 ZNF423 ZNF329 PEG3 OSR2 ZNF200 ZNF236 ZIM3 ZNF891 ZNF710 ZNF77 ZNF12 ZNF334 ZNF197 ZNF616 ZNF799 ZNF615 ZNF468 ZNF333 ZNF548 ZFP2 ZNF554 ZNF646 | 6.41e-24 | 314 | 177 | 32 | PF13912 |
| Domain | EGF_1 | LAMB4 DLL4 MATN1 DNER LRP1B ITGB2 ADAM22 CRB1 EYS CNTNAP5 HMCN2 SCUBE2 EGF MEGF9 ATRNL1 JAG1 SLIT1 CNTNAP2 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 USH2A NOTCH1 NOTCH2 | 6.91e-22 | 255 | 177 | 28 | PS00022 |
| Domain | EGF_2 | LAMB4 DLL4 MATN1 MATN2 DNER LRP1B ITGB2 ADAM22 CRB1 EYS CNTNAP5 HMCN2 SCUBE2 EGF MEGF9 ATRNL1 JAG1 SLIT1 CNTNAP2 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 1.99e-21 | 265 | 177 | 28 | PS01186 |
| Domain | EGF_CA | DLL4 MATN1 MATN2 DNER LRP1B CRB1 EYS HMCN2 SCUBE2 EGF JAG1 SLIT1 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 8.67e-21 | 122 | 177 | 21 | SM00179 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | DLL4 MATN2 DNER LRP1B CRB1 EYS HMCN2 SCUBE2 EGF JAG1 SLIT1 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 1.10e-20 | 106 | 177 | 20 | IPR000152 |
| Domain | EGF-like_Ca-bd_dom | DLL4 MATN1 MATN2 DNER LRP1B CRB1 EYS HMCN2 SCUBE2 EGF JAG1 SLIT1 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 1.24e-20 | 124 | 177 | 21 | IPR001881 |
| Domain | EGF-like_CS | LAMB4 DLL4 MATN1 MATN2 DNER LRP1B ITGB2 ADAM22 CRB1 EYS HMCN2 SCUBE2 EGF MEGF9 ATRNL1 JAG1 SLIT1 CNTNAP2 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 1.92e-20 | 261 | 177 | 27 | IPR013032 |
| Domain | EGF-like_dom | DLL4 MATN1 MATN2 DNER LRP1B ADAM22 CRB1 EYS CNTNAP5 HMCN2 SCUBE2 EGF MEGF9 ATRNL1 JAG1 SLIT1 CNTNAP2 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 8.11e-20 | 249 | 177 | 26 | IPR000742 |
| Domain | Growth_fac_rcpt_ | CRIM1 DLL4 MATN2 INSR DNER LRP1B CRB1 EYS HMCN2 SCUBE2 EGF JAG1 SLIT1 LRP1 SCUBE3 LRP2 NID1 CCN2 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 9.09e-20 | 156 | 177 | 22 | IPR009030 |
| Domain | ASX_HYDROXYL | DLL4 MATN2 DNER LRP1B CRB1 EYS HMCN2 SCUBE2 EGF JAG1 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 9.18e-20 | 100 | 177 | 19 | PS00010 |
| Domain | EGF | DLL4 MATN1 MATN2 DNER LRP1B ADAM22 CRB1 EYS CNTNAP5 SCUBE2 EGF MEGF9 ATRNL1 JAG1 SLIT1 CNTNAP2 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 2.77e-19 | 235 | 177 | 25 | SM00181 |
| Domain | EGF_3 | DLL4 MATN1 MATN2 DNER LRP1B ADAM22 CRB1 EYS CNTNAP5 HMCN2 SCUBE2 EGF ATRNL1 JAG1 SLIT1 CNTNAP2 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 2.77e-19 | 235 | 177 | 25 | PS50026 |
| Domain | EGF_Ca-bd_CS | DNER LRP1B CRB1 EYS HMCN2 SCUBE2 EGF JAG1 SLIT1 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 1.39e-18 | 97 | 177 | 18 | IPR018097 |
| Domain | EGF_CA | DNER LRP1B CRB1 EYS HMCN2 SCUBE2 EGF JAG1 SLIT1 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 2.04e-18 | 99 | 177 | 18 | PS01187 |
| Domain | EGF_CA | MATN1 MATN2 LRP1B HMCN2 SCUBE2 EGF JAG1 LRP1 SCUBE3 LRP2 C1R NID1 LTBP3 ADGRE1 NOTCH1 NOTCH2 | 1.16e-16 | 86 | 177 | 16 | PF07645 |
| Domain | EGF | DLL4 MATN1 MATN2 DNER LRP1B CRB1 EYS SCUBE2 EGF JAG1 SLIT1 CNTNAP2 LRP1 SCUBE3 LRP2 NID1 NOTCH1 NOTCH2 | 1.82e-16 | 126 | 177 | 18 | PF00008 |
| Domain | cEGF | 1.37e-12 | 26 | 177 | 9 | PF12662 | |
| Domain | cEGF | 1.37e-12 | 26 | 177 | 9 | IPR026823 | |
| Domain | hEGF | 1.47e-10 | 28 | 177 | 8 | PF12661 | |
| Domain | Ran_BP1 | 5.87e-10 | 12 | 177 | 6 | PF00638 | |
| Domain | RANBD1 | 5.87e-10 | 12 | 177 | 6 | PS50196 | |
| Domain | RanBD | 1.08e-09 | 13 | 177 | 6 | SM00160 | |
| Domain | Ran_bind_dom | 1.08e-09 | 13 | 177 | 6 | IPR000156 | |
| Domain | - | 2.66e-09 | 39 | 177 | 8 | 2.120.10.30 | |
| Domain | LY | 3.10e-09 | 15 | 177 | 6 | SM00135 | |
| Domain | LDLR_classB_rpt | 3.10e-09 | 15 | 177 | 6 | IPR000033 | |
| Domain | EGF_extracell | 4.91e-09 | 60 | 177 | 9 | IPR013111 | |
| Domain | EGF_2 | 4.91e-09 | 60 | 177 | 9 | PF07974 | |
| Domain | Interferon | 7.55e-09 | 17 | 177 | 6 | PF00143 | |
| Domain | INTERFERON_A_B_D | 7.55e-09 | 17 | 177 | 6 | PS00252 | |
| Domain | Interferon_alpha/beta/delta | 7.55e-09 | 17 | 177 | 6 | IPR000471 | |
| Domain | IFabd | 7.55e-09 | 17 | 177 | 6 | SM00076 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.07e-08 | 46 | 177 | 8 | IPR011042 | |
| Domain | Grip | 3.19e-08 | 11 | 177 | 5 | SM00755 | |
| Domain | GRIP | 3.19e-08 | 11 | 177 | 5 | PF01465 | |
| Domain | GRIP_dom | 5.42e-08 | 12 | 177 | 5 | IPR000237 | |
| Domain | GRIP | 5.42e-08 | 12 | 177 | 5 | PS50913 | |
| Domain | Ldl_recept_b | 1.35e-07 | 14 | 177 | 5 | PF00058 | |
| Domain | LDLRB | 1.35e-07 | 14 | 177 | 5 | PS51120 | |
| Domain | Rab_bind | 2.67e-07 | 7 | 177 | 4 | PF16704 | |
| Domain | GCC2_Rab_bind | 2.67e-07 | 7 | 177 | 4 | IPR032023 | |
| Domain | CTCK_1 | 5.60e-07 | 18 | 177 | 5 | PS01185 | |
| Domain | VWC_out | 7.54e-07 | 19 | 177 | 5 | SM00215 | |
| Domain | InsP3_rcpt-bd | 8.37e-07 | 3 | 177 | 3 | IPR000493 | |
| Domain | SCAN_BOX | 1.22e-06 | 58 | 177 | 7 | PS50804 | |
| Domain | VWC | 1.43e-06 | 38 | 177 | 6 | SM00214 | |
| Domain | LAM_G_DOMAIN | 1.43e-06 | 38 | 177 | 6 | PS50025 | |
| Domain | - | 1.57e-06 | 10 | 177 | 4 | 1.10.220.60 | |
| Domain | CT | 1.67e-06 | 22 | 177 | 5 | SM00041 | |
| Domain | Laminin_G_2 | 1.96e-06 | 40 | 177 | 6 | PF02210 | |
| Domain | VWF_dom | 2.63e-06 | 42 | 177 | 6 | IPR001007 | |
| Domain | Cys_knot_C | 3.29e-06 | 25 | 177 | 5 | IPR006207 | |
| Domain | CTCK_2 | 3.29e-06 | 25 | 177 | 5 | PS01225 | |
| Domain | LamG | 3.48e-06 | 44 | 177 | 6 | SM00282 | |
| Domain | 4_helix_cytokine-like_core | 6.43e-06 | 74 | 177 | 7 | IPR009079 | |
| Domain | TIL_dom | 7.25e-06 | 14 | 177 | 4 | IPR002919 | |
| Domain | - | 7.48e-06 | 50 | 177 | 6 | 1.20.1250.10 | |
| Domain | 4_helix_cytokine_core | 8.41e-06 | 51 | 177 | 6 | IPR012351 | |
| Domain | SCAN | 1.46e-05 | 56 | 177 | 6 | SM00431 | |
| Domain | RIH_assoc-dom | 1.64e-05 | 6 | 177 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 1.64e-05 | 6 | 177 | 3 | PF08709 | |
| Domain | RIH_assoc | 1.64e-05 | 6 | 177 | 3 | PF08454 | |
| Domain | RIH_dom | 1.64e-05 | 6 | 177 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.64e-05 | 6 | 177 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.64e-05 | 6 | 177 | 3 | IPR015925 | |
| Domain | - | 1.64e-05 | 6 | 177 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.64e-05 | 6 | 177 | 3 | PF01365 | |
| Domain | Laminin_G | 1.79e-05 | 58 | 177 | 6 | IPR001791 | |
| Domain | SCAN | 1.79e-05 | 58 | 177 | 6 | PF02023 | |
| Domain | SCAN_dom | 1.79e-05 | 58 | 177 | 6 | IPR003309 | |
| Domain | Retrov_capsid_C | 1.98e-05 | 59 | 177 | 6 | IPR008916 | |
| Domain | VWFC_2 | 2.81e-05 | 38 | 177 | 5 | PS50184 | |
| Domain | DUF5050 | 8.93e-05 | 2 | 177 | 2 | IPR032485 | |
| Domain | DUF5050 | 8.93e-05 | 2 | 177 | 2 | PF16472 | |
| Domain | MIR | 9.56e-05 | 10 | 177 | 3 | PF02815 | |
| Domain | MIR_motif | 9.56e-05 | 10 | 177 | 3 | IPR016093 | |
| Domain | MIR | 9.56e-05 | 10 | 177 | 3 | PS50919 | |
| Domain | MIR | 9.56e-05 | 10 | 177 | 3 | SM00472 | |
| Domain | DUF1220 | 1.31e-04 | 11 | 177 | 3 | PF06758 | |
| Domain | NBPF_dom | 1.31e-04 | 11 | 177 | 3 | IPR010630 | |
| Domain | NBPF | 1.31e-04 | 11 | 177 | 3 | PS51316 | |
| Domain | EGF_dom | 1.73e-04 | 12 | 177 | 3 | IPR024731 | |
| Domain | C8 | 1.73e-04 | 12 | 177 | 3 | PF08742 | |
| Domain | EGF_3 | 1.73e-04 | 12 | 177 | 3 | PF12947 | |
| Domain | TIL | 1.73e-04 | 12 | 177 | 3 | PF01826 | |
| Domain | RECEPTOR_TYR_KIN_II | 1.73e-04 | 12 | 177 | 3 | PS00239 | |
| Domain | EGF_LAM_2 | 1.76e-04 | 30 | 177 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 1.76e-04 | 30 | 177 | 4 | PS01248 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF717 ZNF567 ZNF135 ZFP90 ZNF143 ZNF613 SETD1B ZNF555 ZNF460 ZNF268 USP9X ZNF175 ZNF549 ZNF180 ZNF300 ZNF200 ZKSCAN7 REST ZNF235 ZFP69 INTS3 ZIM3 SMYD2 ZNF710 ZNF77 ZNF12 ZNF334 ZNF544 JAG1 ZNF197 ZNF75D ZNF616 ZNF799 CCN2 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 ZNF614 NOTCH1 NOTCH2 ZNF222 ZNF554 ZNF124 | 1.64e-15 | 1387 | 134 | 47 | M734 |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY | 7.49e-09 | 17 | 134 | 6 | M47564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY | 1.11e-08 | 18 | 134 | 6 | M47539 | |
| Pathway | BIOCARTA_IFNA_PATHWAY | 1.62e-08 | 19 | 134 | 6 | MM1571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY | 1.62e-08 | 19 | 134 | 6 | M47450 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY | 2.29e-08 | 20 | 134 | 6 | M47617 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 3.18e-08 | 21 | 134 | 6 | M47909 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY | 4.34e-08 | 22 | 134 | 6 | M47897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY | 4.34e-08 | 22 | 134 | 6 | M47616 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY | 5.83e-08 | 23 | 134 | 6 | M47452 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 5.83e-08 | 23 | 134 | 6 | MM15634 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY | 7.71e-08 | 24 | 134 | 6 | M47576 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY | 7.71e-08 | 24 | 134 | 6 | M47782 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY | 7.71e-08 | 24 | 134 | 6 | M47908 | |
| Pathway | REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING | 1.30e-07 | 26 | 134 | 6 | M982 | |
| Pathway | BIOCARTA_CYTOKINE_PATHWAY | 2.09e-07 | 28 | 134 | 6 | MM1378 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 3.25e-07 | 30 | 134 | 6 | M936 | |
| Pathway | WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY | 3.99e-07 | 31 | 134 | 6 | M39897 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY | 3.99e-07 | 31 | 134 | 6 | M47964 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 5.59e-07 | 18 | 134 | 5 | MM1549 | |
| Pathway | BIOCARTA_INFLAM_PATHWAY | 5.91e-07 | 33 | 134 | 6 | MM1379 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 7.13e-07 | 34 | 134 | 6 | MM15631 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 8.53e-07 | 35 | 134 | 6 | M48246 | |
| Pathway | KEGG_REGULATION_OF_AUTOPHAGY | 8.53e-07 | 35 | 134 | 6 | M6382 | |
| Pathway | WP_INTERFERONMEDIATED_SIGNALING | 1.20e-06 | 37 | 134 | 6 | M39785 | |
| Pathway | WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE | 1.66e-06 | 39 | 134 | 6 | MM15914 | |
| Pathway | BIOCARTA_IL1R_PATHWAY | 2.26e-06 | 41 | 134 | 6 | MM1493 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 4.91e-06 | 27 | 134 | 5 | M39545 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 5.22e-06 | 13 | 134 | 4 | M47423 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 8.28e-06 | 5 | 134 | 3 | M49000 | |
| Pathway | KEGG_AUTOIMMUNE_THYROID_DISEASE | 9.38e-06 | 52 | 134 | 6 | M13103 | |
| Pathway | KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY | 1.30e-05 | 55 | 134 | 6 | M11844 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 1.64e-05 | 6 | 134 | 3 | M47960 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 2.86e-05 | 7 | 134 | 3 | M27199 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | ZNF823 RGPD4 RGPD2 RANBP2 ZFP90 SETD1B RGPD8 ZNF268 USP9X ZNF180 ZNF300 ZKSCAN7 ZNF235 ZFP69 INTS3 SMYD2 ZNF710 ZNF12 RGPD3 ZNF616 ZNF799 ZNF221 ZFP2 NOTCH1 | 3.09e-05 | 1022 | 134 | 24 | MM15436 |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 3.44e-05 | 65 | 134 | 6 | M272 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.63e-05 | 40 | 134 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 4.10e-05 | 41 | 134 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 4.62e-05 | 42 | 134 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 5.19e-05 | 43 | 134 | 5 | MM14609 | |
| Pathway | KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY | 5.23e-05 | 102 | 134 | 7 | M3261 | |
| Pathway | WP_TOLLLIKE_RECEPTOR_SIGNALING | 5.56e-05 | 103 | 134 | 7 | M39434 | |
| Pathway | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 5.69e-05 | 71 | 134 | 6 | M15913 | |
| Pathway | WP_CYTOSOLIC_DNASENSING_PATHWAY | 6.66e-05 | 73 | 134 | 6 | M39837 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 6.77e-05 | 9 | 134 | 3 | M47852 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 8.02e-05 | 47 | 134 | 5 | MM14939 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 8.46e-05 | 25 | 134 | 4 | MM14511 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 9.60e-05 | 10 | 134 | 3 | M47661 | |
| Pathway | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | 9.67e-05 | 78 | 134 | 6 | M973 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 9.82e-05 | 49 | 134 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.08e-04 | 50 | 134 | 5 | MM14610 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.16e-04 | 27 | 134 | 4 | M12123 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.19e-04 | 51 | 134 | 5 | MM15151 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 1.28e-04 | 82 | 134 | 6 | M1002 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 1.31e-04 | 11 | 134 | 3 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 1.31e-04 | 11 | 134 | 3 | M27466 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.71e-04 | 55 | 134 | 5 | MM14917 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.74e-04 | 12 | 134 | 3 | M47532 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 1.77e-04 | 87 | 134 | 6 | MM15915 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.89e-04 | 88 | 134 | 6 | M16004 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 1.98e-04 | 126 | 134 | 7 | M45009 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 2.01e-04 | 31 | 134 | 4 | M592 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 2.20e-04 | 58 | 134 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 2.20e-04 | 58 | 134 | 5 | MM14736 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.24e-04 | 13 | 134 | 3 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.24e-04 | 13 | 134 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 2.24e-04 | 13 | 134 | 3 | M47751 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 2.24e-04 | 13 | 134 | 3 | MM14553 | |
| Pathway | PID_NOTCH_PATHWAY | 2.39e-04 | 59 | 134 | 5 | M17 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 3.31e-04 | 137 | 134 | 7 | M5669 | |
| Pathway | WP_CANCER_PATHWAYS | LAMB4 ZBTB17 DLL4 IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 EGF JAG1 CTNNA1 NOTCH1 NOTCH2 | 3.32e-04 | 507 | 134 | 14 | M48302 |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 3.39e-04 | 98 | 134 | 6 | M48247 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ZNF823 ZFP90 SETD1B ZNF268 USP9X ZNF180 ZNF300 ZKSCAN7 ZNF235 ZFP69 SMYD2 ZNF710 ZNF12 ZNF616 ZNF799 ZNF221 ZFP2 NOTCH1 | 3.48e-04 | 768 | 134 | 18 | MM14851 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 3.51e-04 | 15 | 134 | 3 | M27202 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 3.77e-04 | 65 | 134 | 5 | MM15147 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 4.30e-04 | 16 | 134 | 3 | M47424 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 4.30e-04 | 16 | 134 | 3 | M26945 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 4.96e-04 | 39 | 134 | 4 | MM14604 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 5.18e-04 | 17 | 134 | 3 | M39389 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 5.94e-04 | 151 | 134 | 7 | M39801 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 6.45e-04 | 73 | 134 | 5 | MM14948 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 7.28e-04 | 19 | 134 | 3 | MM15594 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 7.28e-04 | 19 | 134 | 3 | M27423 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 7.28e-04 | 19 | 134 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 7.28e-04 | 19 | 134 | 3 | M47733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 8.50e-04 | 20 | 134 | 3 | M47688 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 8.60e-04 | 45 | 134 | 4 | M39571 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 8.80e-04 | 5 | 134 | 2 | M27411 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 9.35e-04 | 46 | 134 | 4 | MM15971 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 9.85e-04 | 21 | 134 | 3 | MM15706 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 9.85e-04 | 21 | 134 | 3 | M47689 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 9.93e-04 | 120 | 134 | 6 | M48233 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.01e-03 | 47 | 134 | 4 | M7946 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.09e-03 | 82 | 134 | 5 | MM15922 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.09e-03 | 82 | 134 | 5 | MM15394 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.13e-03 | 22 | 134 | 3 | M27210 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.13e-03 | 22 | 134 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.13e-03 | 22 | 134 | 3 | M47675 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.19e-03 | 49 | 134 | 4 | M618 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.22e-03 | 84 | 134 | 5 | MM14929 | |
| Pubmed | 9.44e-12 | 11 | 185 | 6 | 18835032 | ||
| Pubmed | High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. | 9.44e-12 | 11 | 185 | 6 | 6444699 | |
| Pubmed | Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. | 9.44e-12 | 11 | 185 | 6 | 10448195 | |
| Pubmed | IFN-alpha can both protect against and promote the development of type 1 diabetes. | 9.44e-12 | 11 | 185 | 6 | 19120292 | |
| Pubmed | Effect of interferon-alpha on immediate early gene expression of murine cytomegalovirus. | 9.44e-12 | 11 | 185 | 6 | 8389790 | |
| Pubmed | The mouse IFN-alpha (Ifa) locus: correlation of physical and linkage maps by in situ hybridization. | 9.44e-12 | 11 | 185 | 6 | 3456887 | |
| Pubmed | Mechanism of SUMOylation-Mediated Regulation of Type I IFN Expression. | 9.44e-12 | 11 | 185 | 6 | 36681180 | |
| Pubmed | Type I interferon dependence of plasmacytoid dendritic cell activation and migration. | 9.44e-12 | 11 | 185 | 6 | 15795237 | |
| Pubmed | 9.44e-12 | 11 | 185 | 6 | 9794439 | ||
| Pubmed | 9.44e-12 | 11 | 185 | 6 | 25310498 | ||
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 16565497 | ||
| Pubmed | Regulation of effector and memory T-cell functions by type I interferon. | 1.88e-11 | 12 | 185 | 6 | 21320124 | |
| Pubmed | MAVS Deficiency Is Associated With a Reduced T Cell Response Upon Secondary RSV Infection in Mice. | 1.88e-11 | 12 | 185 | 6 | 33123150 | |
| Pubmed | A novel anti-viral role for STAT3 in IFN-α signalling responses. | 1.88e-11 | 12 | 185 | 6 | 27988795 | |
| Pubmed | Evolution of the interferon alpha gene family in eutherian mammals. | 1.88e-11 | 12 | 185 | 6 | 17512142 | |
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 8656058 | ||
| Pubmed | Repression of the murine interferon alpha 11 gene: identification of negatively acting sequences. | 1.88e-11 | 12 | 185 | 6 | 1886773 | |
| Pubmed | The physical separation of Lps and Ifa loci in BXH recombinant inbred mice. | 1.88e-11 | 12 | 185 | 6 | 2572648 | |
| Pubmed | Developmental control of IFN-alpha expression in murine embryos. | 1.88e-11 | 12 | 185 | 6 | 7925651 | |
| Pubmed | The role of type 1 interferons in coagulation induced by gram-negative bacteria. | 1.88e-11 | 12 | 185 | 6 | 32016282 | |
| Pubmed | Multiple pathways of interferon-induced gene expression in murine macrophages. | 1.88e-11 | 12 | 185 | 6 | 7684767 | |
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 6188104 | ||
| Pubmed | Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells. | 1.88e-11 | 12 | 185 | 6 | 26277892 | |
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 6689487 | ||
| Pubmed | Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. | 1.88e-11 | 12 | 185 | 6 | 18716002 | |
| Pubmed | Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway. | 1.88e-11 | 12 | 185 | 6 | 16611902 | |
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 30967261 | ||
| Pubmed | Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. | 1.88e-11 | 12 | 185 | 6 | 22912583 | |
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 23747509 | ||
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 17434974 | ||
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 18937499 | ||
| Pubmed | Structure and expression of a new murine interferon-alpha gene: MuIFN-alpha I9. | 1.88e-11 | 12 | 185 | 6 | 3758677 | |
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 19406830 | ||
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 8245849 | ||
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 22685550 | ||
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 3017340 | ||
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 20038206 | ||
| Pubmed | Murine alpha/beta interferons inhibit benzo(a)pyrene activation and mutagenesis in mice. | 1.88e-11 | 12 | 185 | 6 | 8304945 | |
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 11846978 | ||
| Pubmed | Identification of distal silencing elements in the murine interferon-A11 gene promoter. | 1.88e-11 | 12 | 185 | 6 | 8760352 | |
| Pubmed | Behavioral effects of mouse interferons-alpha and -gamma and human interferon-alpha in mice. | 1.88e-11 | 12 | 185 | 6 | 1422836 | |
| Pubmed | Role of interferons in the regulation of cell proliferation, differentiation, and development. | 1.88e-11 | 12 | 185 | 6 | 7530016 | |
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 17277125 | ||
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 9794206 | ||
| Pubmed | Isolation and mapping of four new DNA markers from mouse chromosome 4. | 1.88e-11 | 12 | 185 | 6 | 1360280 | |
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 17451966 | ||
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 25897172 | ||
| Pubmed | A polymorphic trinucleotide repeat sequence mapping to distal mouse chromosome 4. | 1.88e-11 | 12 | 185 | 6 | 8672140 | |
| Pubmed | 1.88e-11 | 12 | 185 | 6 | 7601556 | ||
| Pubmed | ZNF567 ZNF555 ZNF460 ZNF235 ZNF77 ZNF7 ZNF197 ZNF799 ZNF615 ZNF468 ZNF614 ZNF554 ZNF124 | 1.90e-11 | 181 | 185 | 13 | 37372979 | |
| Pubmed | Characterization of interferon-alpha 13, a novel constitutive murine interferon-alpha subtype. | 3.47e-11 | 13 | 185 | 6 | 12930842 | |
| Pubmed | Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. | 3.47e-11 | 13 | 185 | 6 | 2014240 | |
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 18005734 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 12050368 | ||
| Pubmed | Isolation and bacterial expression of a murine alpha leukocyte interferon gene. | 3.47e-11 | 13 | 185 | 6 | 6094686 | |
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 2993652 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 1655578 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 2471809 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 21263073 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 8438572 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 38660315 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 9343822 | ||
| Pubmed | Evidence for a different susceptibility of primate lentiviruses to type I interferons. | 3.47e-11 | 13 | 185 | 6 | 23255800 | |
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 7523540 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 19635904 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 19706714 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 23804712 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 22431588 | ||
| Pubmed | Mouse interferon alpha and beta genes are linked at the centromere proximal region of chromosome 4. | 3.47e-11 | 13 | 185 | 6 | 3973562 | |
| Pubmed | Organization, structure and expression of murine interferon alpha genes. | 3.47e-11 | 13 | 185 | 6 | 2987810 | |
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 19130550 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 21469099 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 22739040 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 20065291 | ||
| Pubmed | Effects of IFN alpha on late stages of HIV-1 replication cycle. | 3.47e-11 | 13 | 185 | 6 | 9865497 | |
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 9181467 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 17723216 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 20427526 | ||
| Pubmed | Sequencing and bacterial expression of a novel murine alpha interferon gene. | 3.47e-11 | 13 | 185 | 6 | 18726328 | |
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 18572754 | ||
| Pubmed | 3.47e-11 | 13 | 185 | 6 | 15723075 | ||
| Pubmed | 6.05e-11 | 14 | 185 | 6 | 22815848 | ||
| Pubmed | Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling. | 6.05e-11 | 14 | 185 | 6 | 18981154 | |
| Pubmed | 6.05e-11 | 14 | 185 | 6 | 19620305 | ||
| Pubmed | Interferon induction by HIV glycoprotein 120: role of the V3 loop. | 6.05e-11 | 14 | 185 | 6 | 7526537 | |
| Pubmed | 6.05e-11 | 14 | 185 | 6 | 19559726 | ||
| Pubmed | 6.05e-11 | 14 | 185 | 6 | 15240719 | ||
| Pubmed | 6.05e-11 | 14 | 185 | 6 | 16418394 | ||
| Pubmed | 6.05e-11 | 14 | 185 | 6 | 18272764 | ||
| Pubmed | 6.05e-11 | 14 | 185 | 6 | 11884139 | ||
| Pubmed | 6.05e-11 | 14 | 185 | 6 | 19004943 | ||
| Pubmed | Differential constitutive expression of interferon genes in early mouse embryos. | 6.05e-11 | 14 | 185 | 6 | 7654369 | |
| Pubmed | 6.05e-11 | 14 | 185 | 6 | 2552026 | ||
| Pubmed | Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. | 6.05e-11 | 14 | 185 | 6 | 7532202 | |
| Pubmed | 6.05e-11 | 14 | 185 | 6 | 18200012 | ||
| Pubmed | Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. | 6.05e-11 | 14 | 185 | 6 | 18200009 | |
| Pubmed | Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. | 6.05e-11 | 14 | 185 | 6 | 20566717 | |
| Pubmed | A structural basis for interferon-alpha-receptor interactions. | 6.05e-11 | 14 | 185 | 6 | 17517919 | |
| Pubmed | 6.05e-11 | 14 | 185 | 6 | 21383240 | ||
| Pubmed | 6.05e-11 | 14 | 185 | 6 | 14983024 | ||
| Interaction | RGPD4 interactions | 2.89e-08 | 22 | 178 | 6 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 1.11e-07 | 27 | 178 | 6 | int:RGPD2 | |
| Interaction | RGPD3 interactions | 3.47e-06 | 47 | 178 | 6 | int:RGPD3 | |
| Interaction | RGPD1 interactions | 4.45e-06 | 49 | 178 | 6 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 4.92e-05 | 74 | 178 | 6 | int:RGPD8 | |
| Interaction | NTN5 interactions | 5.45e-05 | 24 | 178 | 4 | int:NTN5 | |
| Interaction | IFNA7 interactions | 5.47e-05 | 9 | 178 | 3 | int:IFNA7 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF567 ZNF132 ZNF135 ZNF613 ZNF460 ZSCAN5A ZNF175 ZNF549 ZNF180 ZNF329 PEG3 ARHGAP35 ZNF235 ZIM3 ZNF835 NANOS2 ZNF544 ZC3H4 ZNF616 ZNF221 ZNF615 ZNF468 ZNF548 ZNF614 ZNF222 | 1.93e-11 | 1192 | 185 | 25 | chr19q13 |
| Cytoband | 9p22 | 6.56e-10 | 25 | 185 | 6 | 9p22 | |
| Cytoband | 19q13.43 | 1.52e-06 | 87 | 185 | 6 | 19q13.43 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p21 | 1.19e-05 | 124 | 185 | 6 | chr9p21 | |
| Cytoband | 19q13.41 | 1.67e-05 | 78 | 185 | 5 | 19q13.41 | |
| Cytoband | 19q13.4 | 1.78e-05 | 79 | 185 | 5 | 19q13.4 | |
| Cytoband | 12q24.33 | 4.32e-05 | 48 | 185 | 4 | 12q24.33 | |
| Cytoband | 19p13.3-p13.2 | 1.42e-03 | 14 | 185 | 2 | 19p13.3-p13.2 | |
| Cytoband | 1q21.1 | 2.04e-03 | 62 | 185 | 3 | 1q21.1 | |
| Cytoband | 2q12.3 | 2.11e-03 | 17 | 185 | 2 | 2q12.3 | |
| Cytoband | 1q41 | 2.44e-03 | 66 | 185 | 3 | 1q41 | |
| Cytoband | 4q25 | 2.55e-03 | 67 | 185 | 3 | 4q25 | |
| Cytoband | 2q13 | 2.66e-03 | 68 | 185 | 3 | 2q13 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF823 ZNF717 ZNF567 ZNF132 ZNF135 ZNF536 ZFP90 ZNF143 ZNF613 ZNF555 ZBTB17 ZSCAN31 ZNF391 ZNF460 ZNF366 ZNF268 ZSCAN5A ZNF175 ZNF549 ZNF423 ZNF180 ZNF329 PEG3 TRPS1 ZNF300 OSR2 ZNF200 ZNF322 ZKSCAN7 ZNF235 ZNF236 ZFP69 ZIM3 ZNF891 ZNF835 ZNF710 ZNF77 ZNF7 ZNF12 ZNF334 ZNF544 GLI4 ZNF197 ZNF75D ZNF616 ZNF799 ZNF221 ZNF615 ZNF468 ZNF333 ZNF679 ZNF548 ZFP2 ZNF614 GLIS1 ZNF222 ZNF554 ZNF124 ZNF646 | 1.36e-42 | 718 | 154 | 59 | 28 |
| GeneFamily | Neuroblastoma breakpoint family | 3.10e-08 | 23 | 154 | 6 | 662 | |
| GeneFamily | Interferons | 2.61e-07 | 32 | 154 | 6 | 598 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 6.06e-07 | 3 | 154 | 3 | 297 | |
| GeneFamily | Low density lipoprotein receptors | 1.63e-04 | 13 | 154 | 3 | 634 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 3.13e-04 | 16 | 154 | 3 | 66 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.54e-04 | 115 | 154 | 6 | 769 | |
| GeneFamily | CD molecules|Mucins | 7.20e-04 | 21 | 154 | 3 | 648 | |
| GeneFamily | SPARC family | 1.95e-03 | 8 | 154 | 2 | 1278 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.99e-03 | 34 | 154 | 3 | 487 | |
| GeneFamily | Complement system|Sushi domain containing | 3.52e-03 | 36 | 154 | 3 | 492 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 4.75e-03 | 40 | 154 | 3 | 321 | |
| Coexpression | NABA_MATRISOME | LAMB4 CRIM1 SPOCK1 INHA MATN1 MATN2 CLEC1A MUC19 SMOC2 ADAM22 IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 EYS HMCN2 SCUBE2 EGF MEGF9 SLIT1 SCUBE3 NID1 CCN2 LTBP3 MUC2 USH2A MUC5AC | 1.45e-10 | 1026 | 183 | 29 | M5889 |
| Coexpression | NABA_MATRISOME | CRIM1 SPOCK1 INHA MATN1 MATN2 CLEC1A MUC19 SMOC2 ADAM22 IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 HMCN2 SCUBE2 EGF MEGF9 SLIT1 SCUBE3 NID1 CCN2 LTBP3 MUC2 MUC5AC | 9.52e-09 | 1008 | 183 | 26 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMB4 CRIM1 MATN1 MATN2 SMOC2 EYS HMCN2 SLIT1 NID1 CCN2 LTBP3 USH2A | 1.46e-08 | 196 | 183 | 12 | M3008 |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_5 | 4.43e-08 | 29 | 183 | 6 | MM586 | |
| Coexpression | NABA_CORE_MATRISOME | LAMB4 CRIM1 SPOCK1 MATN1 MATN2 SMOC2 EYS HMCN2 SLIT1 NID1 CCN2 LTBP3 USH2A | 7.72e-08 | 275 | 183 | 13 | M5884 |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.01e-07 | 33 | 183 | 6 | MM477 | |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 2.87e-07 | 39 | 183 | 6 | M41095 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 5.25e-07 | 43 | 183 | 6 | MM3857 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 1.12e-06 | 27 | 183 | 5 | M40935 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 2.25e-06 | 85 | 183 | 7 | MM684 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP | 2.71e-06 | 32 | 183 | 5 | M40934 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.92e-06 | 16 | 183 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.92e-06 | 16 | 183 | 4 | M2207 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 4.03e-06 | 131 | 183 | 8 | MM1127 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.38e-06 | 191 | 183 | 9 | MM17059 | |
| Coexpression | GSE2706_UNSTIM_VS_2H_LPS_DC_UP | 1.07e-05 | 197 | 183 | 9 | M4695 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAST_CELL_UP | ZNF200 TNFRSF11B SCUBE3 ZNF75D NID1 ROS1 MAP2K7 MUC5AC NOTCH2 | 1.17e-05 | 199 | 183 | 9 | M5397 |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 1.83e-05 | 8 | 183 | 3 | M9884 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 1.87e-05 | 117 | 183 | 7 | M39300 | |
| Coexpression | WORSCHECH_TUMOR_REJECTION_UP | 2.09e-05 | 80 | 183 | 6 | MM1229 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 2.09e-05 | 80 | 183 | 6 | MM646 | |
| Coexpression | NABA_CORE_MATRISOME | 2.16e-05 | 270 | 183 | 10 | MM17057 | |
| Coexpression | NABA_SECRETED_FACTORS | INHA IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 SCUBE2 EGF MEGF9 SCUBE3 | 2.76e-05 | 338 | 183 | 11 | MM17064 |
| Coexpression | NABA_SECRETED_FACTORS | INHA IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 SCUBE2 EGF MEGF9 SCUBE3 | 3.16e-05 | 343 | 183 | 11 | M5883 |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_UP | 3.37e-05 | 87 | 183 | 6 | MM652 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | INHA CLEC1A MUC19 ADAM22 IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 SCUBE2 EGF MEGF9 SCUBE3 MUC2 MUC5AC | 6.53e-05 | 738 | 183 | 16 | MM17058 |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP | 7.42e-05 | 196 | 183 | 8 | M4972 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | INHA CLEC1A MUC19 ADAM22 IFNA4 IFNA7 IFNA10 IFNA16 IFNA17 IFNA21 SCUBE2 EGF MEGF9 SCUBE3 MUC2 MUC5AC | 8.00e-05 | 751 | 183 | 16 | M5885 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | REST TNFRSF11B CRB1 ITPR2 PRDM8 JAG1 SLIT1 LRP1 LRP2 CCN2 ARHGEF4 RAB27A NOTCH1 NOTCH2 | 8.79e-05 | 600 | 183 | 14 | M39055 |
| Coexpression | ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP | 9.05e-05 | 34 | 183 | 4 | M41094 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_ENS_NEURONS | 1.42e-04 | 161 | 183 | 7 | M40214 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP | ZNF567 ZNF143 ZNF555 ZNF77 SLCO5A1 SCUBE2 ZC3H4 ZNF799 ZNF615 ZNF614 ZNF222 ZNF554 | 1.68e-04 | 486 | 183 | 12 | M34018 |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | ZFP90 CRIM1 MATN2 PEG3 REST ARHGAP35 SMOC2 TNFRSF11B OSBPL1A C1R NID1 CCN2 LTBP3 ADGRE1 RAB27A | 1.74e-04 | 721 | 183 | 15 | M1999 |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN | 1.75e-04 | 16 | 183 | 3 | M40964 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 2.09e-04 | 355 | 183 | 10 | M45758 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | CRIM1 SPOCK1 MUC19 LRP1B TNFRSF11B TFF3 CRB1 SLIT1 LRP1 LRP2 CCN2 SIPA1L2 NOTCH2 | 2.11e-04 | 574 | 183 | 13 | M39056 |
| Coexpression | LIU_VAV3_PROSTATE_CARCINOGENESIS_DN | 2.12e-04 | 17 | 183 | 3 | M12393 | |
| Coexpression | MOHANKUMAR_HOXA1_TARGETS_DN | 2.46e-04 | 176 | 183 | 7 | M9032 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#4_top-relative-expression-ranked_100 | 8.11e-06 | 17 | 167 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k4_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_500 | 2.42e-05 | 22 | 167 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_500_k3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ZNF536 SPOCK1 MATN2 PEG3 SMOC2 ADAM22 ZFHX4 ATRNL1 LRP1 NID1 | 5.57e-09 | 185 | 184 | 10 | 3b2dfc8f4c87be516265dbecfc251276034d0efd |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.12e-08 | 199 | 184 | 10 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.18e-08 | 200 | 184 | 10 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.07e-08 | 182 | 184 | 9 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.41e-08 | 183 | 184 | 9 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-07 | 139 | 184 | 8 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-07 | 198 | 184 | 9 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-07 | 198 | 184 | 9 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.67e-07 | 174 | 184 | 8 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-06 | 185 | 184 | 8 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-06 | 185 | 184 | 8 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-06 | 185 | 184 | 8 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.10e-06 | 186 | 184 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 192 | 184 | 8 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-06 | 192 | 184 | 8 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 194 | 184 | 8 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 194 | 184 | 8 | 1374600957c7d7f0b05fd2c1186f521b9096d4ef | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.57e-06 | 195 | 184 | 8 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-06 | 196 | 184 | 8 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-06 | 196 | 184 | 8 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-06 | 197 | 184 | 8 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.83e-06 | 199 | 184 | 8 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 1.83e-06 | 199 | 184 | 8 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.90e-06 | 200 | 184 | 8 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.81e-06 | 148 | 184 | 7 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.07e-06 | 150 | 184 | 7 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 160 | 184 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-06 | 160 | 184 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.99e-06 | 166 | 184 | 7 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.99e-06 | 166 | 184 | 7 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.99e-06 | 166 | 184 | 7 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.73e-06 | 169 | 184 | 7 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.77e-06 | 176 | 184 | 7 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.80e-06 | 179 | 184 | 7 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.80e-06 | 179 | 184 | 7 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-05 | 180 | 184 | 7 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 181 | 184 | 7 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 181 | 184 | 7 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 186 | 184 | 7 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.26e-05 | 186 | 184 | 7 | 8915436d09775f2828a7678af203b1082b36e21c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 186 | 184 | 7 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 186 | 184 | 7 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-05 | 189 | 184 | 7 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 189 | 184 | 7 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 190 | 184 | 7 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-05 | 190 | 184 | 7 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.44e-05 | 190 | 184 | 7 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 191 | 184 | 7 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-05 | 191 | 184 | 7 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.49e-05 | 191 | 184 | 7 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.49e-05 | 191 | 184 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 192 | 184 | 7 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 192 | 184 | 7 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 192 | 184 | 7 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.55e-05 | 128 | 184 | 6 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-05 | 193 | 184 | 7 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 193 | 184 | 7 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-05 | 193 | 184 | 7 | 96c85b250d04b5f400512097d925061c6dc2906b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-05 | 193 | 184 | 7 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 1.60e-05 | 193 | 184 | 7 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.60e-05 | 193 | 184 | 7 | 09de51f8ac509e03d480ed3dc9dfe7e7defc59cb | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.65e-05 | 194 | 184 | 7 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.65e-05 | 194 | 184 | 7 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 194 | 184 | 7 | b0c15e7e4bcf30856fb628dedd7ba82df33489f5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 195 | 184 | 7 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 195 | 184 | 7 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 184 | 7 | 8493f2f60fc356af28b9c0e287d4cd8c8899c081 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 195 | 184 | 7 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 195 | 184 | 7 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 195 | 184 | 7 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aortic_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 184 | 7 | 5e5ca7bd94c9e924ed76f7ccac199be745d4c4eb | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 1.71e-05 | 195 | 184 | 7 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-05 | 196 | 184 | 7 | 023477a499a2c190f363cfdbc9d9c646733a6541 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-05 | 196 | 184 | 7 | 3cb74f1a333a82cac2b459f2f1517e2acf22b5fd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 197 | 184 | 7 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-05 | 197 | 184 | 7 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.88e-05 | 198 | 184 | 7 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-05 | 198 | 184 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.88e-05 | 198 | 184 | 7 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-05 | 198 | 184 | 7 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.88e-05 | 198 | 184 | 7 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.92e-05 | 133 | 184 | 6 | a8abb6b54862123961ae6defbf251ee6e9575258 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 199 | 184 | 7 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-05 | 199 | 184 | 7 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.94e-05 | 199 | 184 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.94e-05 | 199 | 184 | 7 | ca970114b5aef4518ce580897a62ac88688b2671 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-05 | 199 | 184 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-05 | 199 | 184 | 7 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 2.01e-05 | 200 | 184 | 7 | 553386523fd8f8f36617a0d81032224b7ddce442 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.01e-05 | 200 | 184 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.01e-05 | 200 | 184 | 7 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | normal_Lung-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 2.01e-05 | 200 | 184 | 7 | 413ac64bbe95b8c921c5396d8b5f298fec8c4f82 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 200 | 184 | 7 | 5fdca7959134a5c8e06e5d6d14aafe34b963aef2 | |
| ToppCell | COVID-19-Fibroblasts-Mesothelial_FB|COVID-19 / group, cell type (main and fine annotations) | 2.67e-05 | 141 | 184 | 6 | 7e6dcccb74e7ee90b69dc91b59491b84f3a713c9 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.13e-05 | 145 | 184 | 6 | 90ca38c02325c5c637c32efdef634b54cc3cd105 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 3.25e-05 | 146 | 184 | 6 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.65e-05 | 149 | 184 | 6 | 4b44108c40376a6b73258df40d2424e68f991383 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.55e-05 | 155 | 184 | 6 | cd7d95cbcad248670e531d80bb83c55e36ebc573 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 5.24e-05 | 159 | 184 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 5.43e-05 | 160 | 184 | 6 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| Drug | vinylene | ZNF132 ZNF536 ZNF460 ZNF175 ZNF423 ZNF180 PEG3 TRPS1 ZNF300 OSR2 ZNF200 ZKSCAN7 REST ZNF235 TEP1 ZIM3 ZNF197 ZNF333 UHRF2 GLIS1 | 9.38e-15 | 245 | 182 | 20 | CID000006326 |
| Drug | Yfrkd | 1.36e-07 | 7 | 182 | 4 | CID000129984 | |
| Drug | 1hiv | 2.70e-07 | 8 | 182 | 4 | CID005479205 | |
| Drug | Chebi:36708 | 2.70e-07 | 8 | 182 | 4 | CID011966289 | |
| Drug | Ciluprevir [USAN] | 4.35e-07 | 20 | 182 | 5 | CID006450803 | |
| Drug | pipobroman | 7.99e-07 | 10 | 182 | 4 | CID000004842 | |
| Drug | flesinoxan | 1.25e-06 | 11 | 182 | 4 | CID000057347 | |
| Drug | entecavir | 1.96e-06 | 47 | 182 | 6 | CID000153941 | |
| Drug | barium iodide | 2.00e-06 | 4 | 182 | 3 | CID000083684 | |
| Drug | inosiplex | 2.16e-06 | 27 | 182 | 5 | CID000037510 | |
| Drug | R 842 | 2.67e-06 | 13 | 182 | 4 | CID000130714 | |
| Drug | AC1O52EF | 2.67e-06 | 13 | 182 | 4 | CID006450817 | |
| Drug | NSC141633 | 3.14e-06 | 29 | 182 | 5 | CID000003628 | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | LAMB4 ZNF268 ARHGAP35 ZNF710 JAG1 LRP2 ZNF75D MUC2 MAP2K7 NOTCH2 | 3.67e-06 | 193 | 182 | 10 | 4676_UP |
| Drug | Lanicemine | 3.71e-06 | 14 | 182 | 4 | CID003038485 | |
| Drug | gunacin | 3.71e-06 | 14 | 182 | 4 | CID000198547 | |
| Drug | B132 | 4.97e-06 | 5 | 182 | 3 | CID002734031 | |
| Drug | pppA2'-5'A2'-5'A | 5.03e-06 | 15 | 182 | 4 | CID000125229 | |
| Drug | YNK01 | 8.67e-06 | 17 | 182 | 4 | CID000084071 | |
| Drug | HCV-371 | 9.87e-06 | 6 | 182 | 3 | CID003013096 | |
| Drug | p203 | 1.11e-05 | 18 | 182 | 4 | CID000019228 | |
| Drug | podophyllin | 1.11e-05 | 18 | 182 | 4 | CID011979494 | |
| Drug | Nyco | 1.11e-05 | 18 | 182 | 4 | CID000071618 | |
| Drug | anagrelide | 1.25e-05 | 38 | 182 | 5 | CID000002182 | |
| Drug | Jmv 320 | 1.72e-05 | 7 | 182 | 3 | CID003081775 | |
| Drug | val-mCyd | 1.73e-05 | 20 | 182 | 4 | CID006918726 | |
| Drug | L DO | 2.13e-05 | 21 | 182 | 4 | CID000097725 | |
| Drug | peptidomimetic inhibitor | 2.32e-05 | 190 | 182 | 9 | CID005288092 | |
| Drug | emtricitabine | 2.47e-05 | 147 | 182 | 8 | CID000060877 | |
| Drug | formosanin C | 2.58e-05 | 22 | 182 | 4 | CID000073597 | |
| Drug | AC1LAD6M | 2.73e-05 | 8 | 182 | 3 | CID000511663 | |
| Drug | O4-[3-[(1S)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] O1-[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate | 2.73e-05 | 8 | 182 | 3 | CID010011375 | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.97e-05 | 196 | 182 | 9 | 4750_UP | |
| Drug | Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.09e-05 | 197 | 182 | 9 | 5681_UP | |
| Drug | Hiltonol | 3.11e-05 | 23 | 182 | 4 | CID000431963 | |
| Drug | Prednisone [53-03-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.34e-05 | 199 | 182 | 9 | 4400_UP | |
| Drug | AC1L1ZCT | 3.70e-05 | 24 | 182 | 4 | CID000038235 | |
| Drug | cycloferon | 3.70e-05 | 24 | 182 | 4 | CID000038072 | |
| Drug | Telaprevir | 4.07e-05 | 9 | 182 | 3 | CID003010818 | |
| Drug | boceprevir | 4.07e-05 | 9 | 182 | 3 | CID010324367 | |
| Drug | hycanthone | 4.38e-05 | 25 | 182 | 4 | CID000003634 | |
| Drug | LB80380 | 4.38e-05 | 25 | 182 | 4 | CID006480442 | |
| Drug | adefovir dipivoxil | 4.43e-05 | 49 | 182 | 5 | CID000060871 | |
| Drug | ABMP | 5.15e-05 | 26 | 182 | 4 | CID000080567 | |
| Drug | lead stearate | 5.83e-05 | 84 | 182 | 6 | CID000061258 | |
| Drug | VX-497 | 6.00e-05 | 27 | 182 | 4 | CID000153241 | |
| Drug | adenophostin A | 6.36e-05 | 2 | 182 | 2 | ctd:C085029 | |
| Drug | Isocaffeine | 6.36e-05 | 2 | 182 | 2 | CID000001326 | |
| Drug | adenophostin B | 6.36e-05 | 2 | 182 | 2 | CID000656722 | |
| Drug | benzene 1,2,4-trisphosphate | 6.36e-05 | 2 | 182 | 2 | CID000192376 | |
| Drug | AC1NRD2B | 6.96e-05 | 28 | 182 | 4 | CID005289317 | |
| Drug | SC-57099B | 7.91e-05 | 11 | 182 | 3 | CID000178079 | |
| Drug | NM 108 | 8.02e-05 | 29 | 182 | 4 | CID000500901 | |
| Drug | dibutyryl cyclic GMP | 8.59e-05 | 130 | 182 | 7 | CID000036095 | |
| Drug | penciclovir | 9.20e-05 | 30 | 182 | 4 | CID000004725 | |
| Drug | DZNep | 9.20e-05 | 30 | 182 | 4 | CID000073087 | |
| Drug | poly rI:rC | 9.20e-05 | 30 | 182 | 4 | CID011979660 | |
| Drug | casopitant | 1.05e-04 | 12 | 182 | 3 | CID009917021 | |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.08e-04 | 181 | 182 | 8 | 5573_UP | |
| Drug | NMMA | 1.09e-04 | 94 | 182 | 6 | CID000170607 | |
| Drug | CHEMBL466993 | 1.19e-04 | 32 | 182 | 4 | CID005320808 | |
| Drug | isocycloheximide | LAMB4 INSR LRP1B ITGB2 IFNA4 IFNA7 TNFRSF11B IFNA10 IFNA17 NANOS2 EGF CNTN5 ZNF197 LRP1 LRP2 ZNF75D PRKCH ART5 NANOS1 | 1.23e-04 | 905 | 182 | 19 | CID000002900 |
| Drug | AC1L1O6Q | 1.43e-04 | 141 | 182 | 7 | CID000058035 | |
| Drug | carprofen | 1.52e-04 | 34 | 182 | 4 | CID000002581 | |
| Drug | oxymatrine | 1.52e-04 | 34 | 182 | 4 | CID000114850 | |
| Drug | tenofovir disoproxil fumarate | 1.52e-04 | 34 | 182 | 4 | CID005481350 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.68e-04 | 193 | 182 | 8 | 5914_UP | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.68e-04 | 193 | 182 | 8 | 7147_UP | |
| Drug | tilorone | 1.70e-04 | 35 | 182 | 4 | CID000005475 | |
| Drug | lobucavir | 1.70e-04 | 35 | 182 | 4 | CID000060786 | |
| Drug | AMT hydrochloride | 1.71e-04 | 14 | 182 | 3 | CID000001534 | |
| Drug | mesobiliverdin IValpha | 1.71e-04 | 14 | 182 | 3 | CID004478237 | |
| Drug | fura 2 | 1.73e-04 | 65 | 182 | 5 | CID000057054 | |
| Drug | AC1L1JM9 | ARHGAP35 ITGB2 IFNA4 IFNA7 IFNA10 IFNA17 KAT7 EGF PRKCH ART5 | 1.76e-04 | 304 | 182 | 10 | CID000005103 |
| Drug | Ceforanide [60925-61-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.80e-04 | 195 | 182 | 8 | 3309_UP | |
| Drug | 5-deoxy-5-fluoro-myo-inositol | 1.90e-04 | 3 | 182 | 2 | CID000195110 | |
| Drug | MCNU | 1.91e-04 | 36 | 182 | 4 | CID000071741 | |
| Drug | AC1L3PKB | 1.91e-04 | 36 | 182 | 4 | CID000119830 | |
| Drug | A809128 | 1.91e-04 | 36 | 182 | 4 | CID003392279 | |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 1.93e-04 | 197 | 182 | 8 | 3540_UP | |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; HL60; HT_HG-U133A | 1.93e-04 | 197 | 182 | 8 | 3045_UP | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A | 1.93e-04 | 197 | 182 | 8 | 3797_DN | |
| Drug | Loxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.00e-04 | 198 | 182 | 8 | 1516_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.00e-04 | 198 | 182 | 8 | 5425_UP | |
| Drug | Bisoprolol fumarate; Up 200; 9uM; PC3; HT_HG-U133A | 2.00e-04 | 198 | 182 | 8 | 6748_UP | |
| Drug | AC1L1G9T | INSR ARHGAP35 ITGB2 IFNA4 IFNA7 IFNA10 IFNA17 ZNF77 EGF PRKCH ART5 NANOS1 | 2.00e-04 | 433 | 182 | 12 | CID000003591 |
| Drug | AC1Q5H8E | 2.01e-04 | 149 | 182 | 7 | CID000114813 | |
| Drug | Rolitetracycline [751-97-3]; Up 200; 7.6uM; PC3; HT_HG-U133A | 2.07e-04 | 199 | 182 | 8 | 6731_UP | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A | 2.07e-04 | 199 | 182 | 8 | 4334_UP | |
| Drug | Clozapine [5786-21-0]; Down 200; 12.2uM; PC3; HT_HG-U133A | 2.07e-04 | 199 | 182 | 8 | 4670_DN | |
| Drug | Probucol [23288-49-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 2.07e-04 | 199 | 182 | 8 | 4666_UP | |
| Drug | Proxyphylline [603-00-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 2.07e-04 | 199 | 182 | 8 | 7290_UP | |
| Drug | Pesticides | 2.09e-04 | 150 | 182 | 7 | ctd:D010575 | |
| Drug | pyran | 2.12e-04 | 37 | 182 | 4 | CID000033703 | |
| Drug | FMAU | 2.12e-04 | 37 | 182 | 4 | CID000072327 | |
| Drug | anad | 2.13e-04 | 15 | 182 | 3 | CID005287574 | |
| Drug | l956 | 2.13e-04 | 15 | 182 | 3 | CID000017814 | |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; PC3; HT_HG-U133A | 2.14e-04 | 200 | 182 | 8 | 4677_UP | |
| Drug | Acemetacin [53164-05-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.14e-04 | 200 | 182 | 8 | 5460_UP | |
| Drug | SB 203580; Up 200; 1uM; PC3; HT_HG-U133A | 2.14e-04 | 200 | 182 | 8 | 6894_UP | |
| Disease | YKL40 measurement, cerebrospinal fluid biomarker measurement | 1.73e-06 | 5 | 166 | 3 | EFO_0004869, EFO_0006794 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 9.59e-06 | 8 | 166 | 3 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Hepatic ductular hypoplasia | 3.15e-05 | 2 | 166 | 2 | C2930797 | |
| Disease | Alagille syndrome (is_implicated_in) | 3.15e-05 | 2 | 166 | 2 | DOID:9245 (is_implicated_in) | |
| Disease | Alagille Syndrome 2 | 3.15e-05 | 2 | 166 | 2 | C1857761 | |
| Disease | Hypoxic Brain Damage | 3.15e-05 | 2 | 166 | 2 | C1140716 | |
| Disease | Alagille Syndrome 1 | 3.15e-05 | 2 | 166 | 2 | C1956125 | |
| Disease | lung large cell carcinoma (biomarker_via_orthology) | 3.15e-05 | 2 | 166 | 2 | DOID:4556 (biomarker_via_orthology) | |
| Disease | cystitis (is_marker_for) | 3.15e-05 | 2 | 166 | 2 | DOID:1679 (is_marker_for) | |
| Disease | lung small cell carcinoma (biomarker_via_orthology) | 3.15e-05 | 2 | 166 | 2 | DOID:5409 (biomarker_via_orthology) | |
| Disease | Anoxic Encephalopathy | 3.15e-05 | 2 | 166 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 3.15e-05 | 2 | 166 | 2 | C1527348 | |
| Disease | hemophagocytic lymphohistiocytosis (implicated_via_orthology) | 3.15e-05 | 2 | 166 | 2 | DOID:0050120 (implicated_via_orthology) | |
| Disease | Anoxia of brain | 3.15e-05 | 2 | 166 | 2 | C0995195 | |
| Disease | Alagille Syndrome | 3.15e-05 | 2 | 166 | 2 | C0085280 | |
| Disease | Arteriohepatic dysplasia | 3.15e-05 | 2 | 166 | 2 | cv:C0085280 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 3.71e-05 | 12 | 166 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | xanthine measurement | 4.80e-05 | 13 | 166 | 3 | EFO_0010548 | |
| Disease | COVID-19, mortality | 5.24e-05 | 170 | 166 | 7 | EFO_0004352, MONDO_0100096 | |
| Disease | nitric oxide exhalation measurement | 6.14e-05 | 38 | 166 | 4 | EFO_0005536 | |
| Disease | sputum mucin-5B amount | 9.40e-05 | 3 | 166 | 2 | OBA_2050332 | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 1.12e-04 | 17 | 166 | 3 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 1.82e-04 | 50 | 166 | 4 | DOID:3770 (biomarker_via_orthology) | |
| Disease | lung adenocarcinoma (biomarker_via_orthology) | 1.87e-04 | 4 | 166 | 2 | DOID:3910 (biomarker_via_orthology) | |
| Disease | serum IgG glycosylation measurement | ZNF423 TRPS1 DNER LRP1B SMYD2 EYS CNTNAP5 EGF SLIT1 CNTNAP2 USH2A | 1.95e-04 | 523 | 166 | 11 | EFO_0005193 |
| Disease | obesity (implicated_via_orthology) | 2.25e-04 | 215 | 166 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | response to bronchodilator, response to corticosteroid | 3.11e-04 | 5 | 166 | 2 | GO_0031960, GO_0097366 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 3.11e-04 | 5 | 166 | 2 | DOID:3030 (is_marker_for) | |
| Disease | alopecia (implicated_via_orthology) | 3.11e-04 | 5 | 166 | 2 | DOID:987 (implicated_via_orthology) | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 4.63e-04 | 27 | 166 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | Adams Oliver syndrome | 4.65e-04 | 6 | 166 | 2 | C0265268 | |
| Disease | Congenital defect of skull and scalp | 4.65e-04 | 6 | 166 | 2 | C2931779 | |
| Disease | Adams-Oliver syndrome 1 | 4.65e-04 | 6 | 166 | 2 | C4551482 | |
| Disease | Adams-Oliver syndrome (is_implicated_in) | 4.65e-04 | 6 | 166 | 2 | DOID:0060227 (is_implicated_in) | |
| Disease | dry eye syndrome (implicated_via_orthology) | 4.65e-04 | 6 | 166 | 2 | DOID:10140 (implicated_via_orthology) | |
| Disease | blood nickel measurement | 6.00e-04 | 120 | 166 | 5 | EFO_0007583 | |
| Disease | anxiety, smoking behaviour measurement | 6.49e-04 | 7 | 166 | 2 | EFO_0005230, EFO_0005671 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 6.49e-04 | 7 | 166 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 6.49e-04 | 7 | 166 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | pentachlorophenol measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022071 | |
| Disease | parathion measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022070 | |
| Disease | potassium chromate measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022067 | |
| Disease | methoxychlor measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022055 | |
| Disease | aldrin measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022054 | |
| Disease | dicofol measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022060 | |
| Disease | disulfoton measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022062 | |
| Disease | dieldrin measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022061 | |
| Disease | endrin measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022064 | |
| Disease | endosulfan measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022063 | |
| Disease | heptachlor measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022066 | |
| Disease | ethion measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022056 | |
| Disease | diazinon measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0022058 | |
| Disease | environmental exposure measurement | 7.77e-04 | 73 | 166 | 4 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 8.18e-04 | 74 | 166 | 4 | EFO_0007886 | |
| Disease | bipolar II disorder | 8.61e-04 | 8 | 166 | 2 | EFO_0009964 | |
| Disease | pack-years measurement, systolic blood pressure | 9.20e-04 | 34 | 166 | 3 | EFO_0006335, EFO_0006526 | |
| Disease | Glioblastoma | 1.05e-03 | 79 | 166 | 4 | C0017636 | |
| Disease | hemangiopericytoma (is_marker_for) | 1.10e-03 | 9 | 166 | 2 | DOID:264 (is_marker_for) | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 1.10e-03 | 9 | 166 | 2 | EFO_0009824 | |
| Disease | Giant Cell Glioblastoma | 1.31e-03 | 84 | 166 | 4 | C0334588 | |
| Disease | Bone Diseases | 1.37e-03 | 10 | 166 | 2 | C0005940 | |
| Disease | Disorders of Intracellular Cobalamin Metabolism | 1.37e-03 | 10 | 166 | 2 | cv:CN043592 | |
| Disease | pneumonia (implicated_via_orthology) | 1.37e-03 | 10 | 166 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | allergic rhinitis (biomarker_via_orthology) | 1.37e-03 | 10 | 166 | 2 | DOID:4481 (biomarker_via_orthology) | |
| Disease | psychosocial stress measurement | 1.67e-03 | 11 | 166 | 2 | EFO_0006783 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 2.00e-03 | 12 | 166 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 2.00e-03 | 12 | 166 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | triacylglycerol 58:12 measurement | 2.00e-03 | 12 | 166 | 2 | EFO_0010439 | |
| Disease | body weight | ZNF143 CRIM1 SPOCK1 ZNF423 INSR TRPS1 WDR70 CHD7 DCST2 LRP1B CRB1 ITPR1 EYS SLIT1 CHFR LTBP3 | 2.08e-03 | 1261 | 166 | 16 | EFO_0004338 |
| Disease | Adenocarcinoma of large intestine | 2.15e-03 | 96 | 166 | 4 | C1319315 | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 2.36e-03 | 13 | 166 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.36e-03 | 13 | 166 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | major depressive episode | 2.36e-03 | 47 | 166 | 3 | EFO_0007634 | |
| Disease | blood cobalt measurement | 2.58e-03 | 101 | 166 | 4 | EFO_0007577 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 2.66e-03 | 49 | 166 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | hemoglobin A1 measurement | 2.83e-03 | 520 | 166 | 9 | EFO_0007629 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 3.15e-03 | 15 | 166 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 3.15e-03 | 15 | 166 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 3.15e-03 | 15 | 166 | 2 | C0154091 | |
| Disease | attempted suicide | 3.42e-03 | 178 | 166 | 5 | EFO_0004321 | |
| Disease | Dermatitis | 3.58e-03 | 16 | 166 | 2 | C0011603 | |
| Disease | Glioblastoma Multiforme | 3.63e-03 | 111 | 166 | 4 | C1621958 | |
| Disease | grip strength measurement | 3.79e-03 | 350 | 166 | 7 | EFO_0006941 | |
| Disease | vascular endothelial growth factor measurement | 3.90e-03 | 56 | 166 | 3 | EFO_0004762 | |
| Disease | response to statin | 3.90e-03 | 56 | 166 | 3 | GO_0036273 | |
| Disease | phosphoglyceric acid measurement | 4.05e-03 | 17 | 166 | 2 | EFO_0010523 | |
| Disease | lupus nephritis (is_marker_for) | 4.05e-03 | 17 | 166 | 2 | DOID:0080162 (is_marker_for) | |
| Disease | information processing speed, response to cranial radiation therapy | 4.30e-03 | 58 | 166 | 3 | EFO_0004363, EFO_0010950 | |
| Disease | adult onset asthma | 4.51e-03 | 118 | 166 | 4 | EFO_1002011 | |
| Disease | bipolar disorder, sex interaction measurement | 4.54e-03 | 18 | 166 | 2 | EFO_0008343, MONDO_0004985 | |
| Disease | ischemia (biomarker_via_orthology) | 4.54e-03 | 18 | 166 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | nephrotic syndrome (is_marker_for) | 4.54e-03 | 18 | 166 | 2 | DOID:1184 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFPTYCQQKSLECLH | 81 | P05156 | |
| KNISSNYCLGRHLPC | 221 | Q9N2K0 | |
| SQCAPNIHKMDGYSC | 521 | Q9P0K1 | |
| SEYCNNHPNACVELS | 376 | Q9NR80 | |
| CHEQNGYCSKPAECL | 226 | Q9NR61 | |
| CDQDLNYCTHHSPCK | 281 | Q9NR61 | |
| KPAVLYDCNCAGASE | 51 | Q96LT6 | |
| NLGQAYPCSSDKECE | 71 | Q9UBU2 | |
| CRPGYELQEDTHSCQ | 176 | P00736 | |
| CCNHPYLINGAEEKI | 1251 | Q9P2D1 | |
| SLNQRCSCPDAYKHL | 1266 | Q96F81 | |
| KYGPCANHVEPSENC | 846 | Q9BYT9 | |
| NPSEAKDSGHYQCLA | 161 | O94779 | |
| EKCNSHHSSYQPLCL | 501 | P49792 | |
| AYCENPDIVLCGNKS | 121 | P51159 | |
| KEKCNSHHSSYQPLC | 501 | Q99666 | |
| KEKCNSHHSSYQPLC | 501 | O14715 | |
| NAYVCKGLPQHEEIC | 76 | Q68E01 | |
| SLTEYCQGPCHENQT | 1991 | Q14571 | |
| LETLTEYCQGPCHEN | 1941 | Q14573 | |
| RKPNGYRCSHDSECQ | 76 | A6NCL2 | |
| SNCNLKHIDEVIYPC | 156 | Q96K12 | |
| KCIDHPNGYECQCAT | 546 | Q04721 | |
| LNCPHCDYKTADRSN | 361 | Q13127 | |
| YKSICSLGCDLPQTH | 16 | P01566 | |
| ISGCPLYHNLSADEC | 206 | O95251 | |
| QYDVDECASTPCKNG | 526 | P46531 | |
| EGYHDPTCLSEVNEC | 706 | P46531 | |
| SGCSQDCQDLPVSYK | 2936 | Q9NZR2 | |
| PCGDDAYCNQIKTSV | 3811 | Q9NZR2 | |
| DHDCEQVCISSPGSY | 231 | P21941 | |
| DSYSCHCLKGFTLNP | 381 | O00339 | |
| HCQPPFSGKYCQELD | 201 | Q5T1H1 | |
| ESLTEYCQGPCHENQ | 2046 | Q14643 | |
| LDDCHYNQLCENTPG | 4721 | Q8NDA2 | |
| PDNHTCQIQSYCAKH | 1216 | Q07954 | |
| YKSICSLGCDLPQTH | 16 | P01568 | |
| QSYFCGELTPHQCVE | 6131 | Q5CZC0 | |
| LCGASGDNAHTIKYC | 251 | Q8WY41 | |
| LKSHDCPYIVQCFGT | 171 | O14733 | |
| CHNKVDPSAYHDACI | 1481 | Q7Z5P9 | |
| VEKECPCVHNNDLYS | 816 | Q02817 | |
| PCVHNNDLYSSGAKI | 821 | Q02817 | |
| DALQNPCYIGTHGCD | 666 | P14543 | |
| YCETGLHNCDIPQRA | 761 | P14543 | |
| YKSICSLGCDLPQTH | 16 | P01567 | |
| QGLHCETCKEGFYLN | 231 | Q9H1U4 | |
| NQISVYKCGDCPSAD | 446 | O95163 | |
| SNGQCIPSEYRCDHV | 116 | P98164 | |
| CLYGSDEHNACVPKT | 1256 | P98164 | |
| DEHNACVPKTCPSSY | 1261 | P98164 | |
| NCPDRTCQSGYTKCH | 2816 | P98164 | |
| TCPQHCRNTKGSYEC | 4016 | P98164 | |
| DTGKCVQASNCPCYH | 751 | P98088 | |
| PAVKVADQDGCCHHY | 4901 | P98088 | |
| IHNNKCIPECPSGYT | 306 | P06213 | |
| CGHCQALAPEYSKAA | 71 | Q13087 | |
| LTHTDIKPYSCEQCG | 276 | Q8N2R0 | |
| CSDQLGNTPLHCAAY | 171 | Q9BXW6 | |
| LEECAITCSNSHGPY | 746 | Q3BBV0 | |
| CGATGDQAHTLKYCP | 101 | P60321 | |
| QLYECPKCGESFIHS | 1161 | Q9GZU2 | |
| QCPFTCLEKSHLYNH | 41 | P0CG20 | |
| QCLCHTSDVPGKLIY | 516 | P05107 | |
| KEKCNSHHSSYQPLC | 501 | A6NKT7 | |
| VQDYVCPLQGSHALC | 471 | Q96EP1 | |
| KDELQYCALSNGHAC | 776 | Q711Q0 | |
| HCPDSACKQDLLAYL | 766 | P35221 | |
| VYLNPEQHCCQESSD | 641 | P41002 | |
| NSDSECPLSHDGYCL | 971 | P01133 | |
| KTCACHYNCPGDNDI | 321 | P29279 | |
| EGQGCVHYNLKTSCP | 426 | Q8ND61 | |
| SCSKICPLGFQQDSH | 571 | Q9NZV1 | |
| QRLHTGEKPYACSQC | 286 | P10075 | |
| YSINSCPNNCSGHGK | 206 | Q5VV63 | |
| CPQGYKRLNSTHCQD | 341 | Q9NS15 | |
| LKNVSSNAECPACYE | 116 | Q6UX82 | |
| KYETVPNLLTQHCAC | 351 | P05111 | |
| YSKAQDDCNRGACHP | 16 | A4D0S4 | |
| CKPGHYGSALNQTCR | 1006 | A4D0S4 | |
| HCDQLTGQCPCKLGY | 1091 | A4D0S4 | |
| GYVCNCHIPTRNASK | 126 | Q3LI83 | |
| EPSCEAYKHLGQTSN | 596 | Q9UHC6 | |
| DVCNSELGNPYLKCA | 196 | Q5T1A1 | |
| HLDTKPYACQIPGCS | 316 | Q8NBF1 | |
| ICPHNYSGVNCELEI | 211 | P82279 | |
| NPCLHGGNCEDIYSS | 1146 | P82279 | |
| CACGQPAYAHDTVVE | 156 | A4D161 | |
| IKDILCQECSPYAAH | 101 | Q6UWX4 | |
| DSYDAAVACKQLGCP | 296 | Q86VB7 | |
| ELYKDPCANVSCLNG | 541 | Q8NFT8 | |
| CHADALCQNTPTSYK | 56 | Q9NQ36 | |
| QDCETRVQCSPGHFY | 746 | Q9NQ36 | |
| QDCDTKVQCSPGHYY | 741 | Q8IX30 | |
| VQQCGIHSKQACYPL | 186 | P46059 | |
| YKSICSLGCDLPQTH | 16 | P01571 | |
| KHNGYLCDCTNSPYE | 976 | Q8WYK1 | |
| QLCDKDLNYCGTHQP | 291 | P78504 | |
| SSEAKVCCNGVLYNP | 3186 | O75445 | |
| DLLEGANAYHCEKCN | 1761 | Q93008 | |
| KEKCNSHHSSYQPLC | 501 | Q7Z3J3 | |
| QQTCGNVPYCASSKH | 871 | Q5TCX8 | |
| EECAITCSNSHGPYD | 441 | Q3BBV2 | |
| EECAITCSNSHGPYD | 476 | Q86T75 | |
| LEECAITCSNSHGPY | 746 | Q5TAG4 | |
| EECAITCSNSHGPYD | 136 | Q5TI25 | |
| EECAITCSNSHGPYD | 136 | B4DH59 | |
| EKCNSHHSSYQPLCL | 501 | P0DJD1 | |
| YKSICSLGCDLPQTH | 16 | P05015 | |
| HNKMNGSSPYTCLEC | 146 | Q9NQV8 | |
| NVNCGCKIHEYEPVC | 556 | Q9H2Y9 | |
| KVHNPCTENVCYSVG | 736 | Q9P2F8 | |
| HSCNPNCYAKVITVE | 1906 | Q9UPS6 | |
| QLHVFETCYNPKGLC | 131 | Q5MNZ6 | |
| YKSICSLGCDLPQTH | 16 | P05014 | |
| CNCLYNIDAKPEEPH | 201 | Q16651 | |
| FQPHGCLCLYNSKES | 656 | Q9NRY4 | |
| KGNNCRDSTLCPAYA | 31 | Q14246 | |
| ECHPYLTQKNLISFC | 196 | Q96JD6 | |
| YNKAGAHRCSPCTEQ | 126 | Q8NC01 | |
| NCEENQHSDSCYKLG | 61 | Q96BR5 | |
| NTTDDYRKCPSNCGQ | 216 | Q70EK8 | |
| YQPVTTECFHNVCKD | 741 | Q96PU4 | |
| RTHTAEKPYICNDCG | 476 | Q8N8J6 | |
| QTHTGEKPYKCNECD | 616 | Q8N8J6 | |
| DCGYPHVTPKECNNR | 41 | Q07654 | |
| QRTHTGEKPYECNDC | 356 | Q8N184 | |
| VCNACGLYQKLHSTP | 916 | Q9UHF7 | |
| RTHTGEQPYACKQCG | 296 | P16415 | |
| VHTQVRPYECSQCGK | 396 | P52740 | |
| QKVHTGQRPYECSEC | 506 | P52740 | |
| THAEERPYKCENCGN | 216 | Q96PE6 | |
| EGKNCTLQCNYTVSP | 36 | A0A0B4J240 | |
| AIGNPVHLKCNACDY | 966 | Q86UP3 | |
| YDEETSHQLLCDKCP | 31 | O00300 | |
| RTHSGEKPYECNQCG | 456 | Q15935 | |
| FNIHTGEKPYECLQC | 411 | Q14592 | |
| QRLHNGEKPYECNEC | 641 | O14709 | |
| HTGEKPYRCSEDNCT | 291 | P52747 | |
| RVHTGEKPYQCSQCS | 371 | Q96LW9 | |
| RSHTGQKPYICNECG | 261 | Q08AN1 | |
| YECNQCGKAFSHPSS | 396 | Q8NEP9 | |
| QKVHSGERPYNCTAC | 576 | Q6P9A3 | |
| PYECHECLKGFRNSS | 241 | P52742 | |
| PYECHECGKAFTQIT | 381 | P52742 | |
| QRIHTGEKPYECNQC | 541 | P52742 | |
| QRTHTGEKPYSCNEC | 631 | Q14587 | |
| HTGQRPYECNECGKT | 566 | Q9HCZ1 | |
| QRTHTGEKPYECNEC | 591 | Q9HCZ1 | |
| KAHQYQITGCCLSPD | 1756 | Q99973 | |
| YHGAQVCSGTNPRKC | 6 | A0A1B0GUW6 | |
| PECNDDGTYSQVQCH | 111 | Q9H3U7 | |
| PCECHQIKSLQYSNT | 226 | Q9NW82 | |
| PVQNGALYCVCHKST | 21 | Q9Y6G3 | |
| HTRENSYQCEECGKP | 206 | Q8IYX0 | |
| QRSHTGEKPYLCSEC | 146 | Q6U7Q0 | |
| HTGERPYTCDVCQKQ | 406 | Q9BUG6 | |
| HQTGVYPCSLCSKQL | 396 | O15015 | |
| CSPHKVCVTQDYQTA | 91 | Q08629 | |
| LASHQGPTLYQCLEC | 426 | Q8N1W2 | |
| GPTLYQCLECDKSFH | 431 | Q8N1W2 | |
| TTHTDEKPYACQQCG | 301 | Q96GE5 | |
| HVKTSCSQGPAYVCN | 1701 | P08922 | |
| QEAYSHCLISGQKGC | 826 | Q8N841 | |
| FPCKLYHTTGNCING | 446 | Q9UPT8 | |
| QRTHTGEKPYDCNHC | 271 | P98182 | |
| HYGCTICEKVFNIPS | 121 | Q15973 | |
| YECNQCGKPFRTSTH | 506 | Q96JL9 | |
| THSAGRPYQCNQCEK | 611 | Q96JL9 | |
| CPHCDYAGTQSASLK | 781 | O15090 | |
| FHKCNSCPIDGQVIY | 376 | Q8NEG5 | |
| QRTHAGEKPYACNEC | 526 | Q9BY31 | |
| QRTHTGEKPYECNQC | 456 | Q9UJW8 | |
| QRTHTGEKPYECSQC | 596 | Q9UJW8 | |
| PNTHILYACDSCGDK | 711 | Q13105 | |
| HTGEQPYTCSLCKRN | 471 | P51815 | |
| QRSHNGEKPYNCEEC | 441 | Q9UK13 | |
| THRGPIQYNCSECDK | 386 | Q8N895 | |
| QRTHTGEKPYECNLC | 511 | Q6NX49 | |
| QRNHTGEKPYECTEC | 251 | Q6PF04 | |
| HSGERPYECSECQKA | 471 | Q8NEK5 | |
| HTGERPYACAQCAKA | 216 | Q9Y2P0 | |
| QRTHTGEKPYECNEC | 486 | Q9P0L1 | |
| HSEVKNGPTYNCTEC | 276 | Q9UL36 | |
| QRTHTGEKPYECNEC | 316 | P17014 | |
| SISNGEYPCNQCDLK | 626 | Q2M1K9 | |
| VHGQEDKIYDCSQCP | 1251 | Q2M1K9 | |
| QRSHTGEKPYECSQC | 261 | Q6ZN57 | |
| QRTHTGEKPYECNEC | 446 | Q8N883 | |
| NHSCCPNVIVTYKGT | 206 | Q9NRG4 | |
| YQLNSECNSDVVCPH | 501 | O75093 | |
| AGNSCNIKHTEAPLY | 666 | Q13308 | |
| ACKNGDECAYHHPIS | 606 | Q6PJT7 | |
| PYTCHECGKSFNQSS | 346 | Q14590 | |
| TILHTGEKPYTCNEC | 346 | Q5VIY5 | |
| QRTHTGEKPYECNQC | 446 | Q86UD4 | |
| CCVPGCYNNSHRDKA | 6 | Q96EK4 | |
| QRTHTGEKPYDCSEC | 316 | Q96RE9 | |
| RTHTGEKPYECNQCG | 396 | A8MT65 | |
| CAHCRTPLQKGQTAY | 311 | Q14202 | |
| QRSHTGEKPYQCHNC | 466 | Q9Y473 | |
| TNNCHGEKPYECAEC | 241 | P17097 | |
| QQLYSGEKSHTCDEC | 136 | Q9UK12 | |
| RTHTGEKPYGCNECQ | 306 | B1APH4 | |
| QRTHTGEKPYACSEC | 346 | B1APH4 | |
| ENAHTGEKPYQCSLC | 301 | Q8TF47 | |
| QRHHTGEKPYECNEC | 486 | Q49AA0 | |
| QRTHTGEKPYECNEC | 156 | Q9UJN7 | |
| RTHTGENPYECKQCG | 456 | Q86TJ5 | |
| HNYKVPTFCDHCGSL | 251 | P24723 | |
| QTCSHFNCAYLGGEK | 251 | Q96L15 |